Page last updated: 2024-08-21

nandrolone and dienogest

nandrolone has been researched along with dienogest in 374 studies

Research

Studies (374)

TimeframeStudies, this research(%)All Research%
pre-199051 (13.64)18.7374
1990's25 (6.68)18.2507
2000's71 (18.98)29.6817
2010's167 (44.65)24.3611
2020's60 (16.04)2.80

Authors

AuthorsStudies
Das, RP; Sharma, RK2
Boer, J; Carol, W; Klinger, G; Michels, W; Pocha, C1
Buchmann, J; Kaltwasser, P; Rothe, K; Schneider, F; Seliger, E1
Band, V; Farooq, A; Kharbanda, SM; Murugesan, K1
Bhatti, DP; Chaudhary, J; Das, RP; Majumdar, SS; Misro, MM; Sharma, RK1
Balogh, A; Hoffmann, A; Klinger, G; Liewald, S; Liewald, T; Schröder, S; Splinter, FC1
Chaudhary, J; Das, RP; Majumdar, SS; Sharma, RK1
Gupta, G; Setty, BS; Srivastava, A1
Hillesheim, HG; Hobe, G; Ritter, P; Valentin, U1
Hillesheim, HG; Hobe, G; Ritter, P; Schade, W; Schön, R; Wehrberger, K1
Brachmann, K; Göretzlehner, G; Köhler, G1
Köhler, G; Männchen, E; Nikschick, S1
Carol, W; Jäger, R; Martin, P; Möller, U1
Brachmann, K; Foth, D; Happke, S; Köhler, G; Lembke, S1
Farooq, A; Kalita, JC; Murugesan, K; Vij, U1
Göretzlehner, G; Köhler, G1
Band, V; Bhargava, VL; Farooq, A; Kharbanda, SM; Murugesan, K; Verma, U1
Ahrendt, HJ; Amon, I; Canzler, E; Köhler, G; Lembke, S1
Das, RP; Majumdar, SS; Sharma, RK1
Maikhuri, JP; Setty, BS; Srivastava, A1
Erdmann, A; Hobe, G; Klinger, G; Reddersen, G1
Amon, I; Göretzlehner, G; Köhler, G1
Frankenberg, G; Hobe, G; Hübner, M; Menzenbach, B; Reddersen, G; Römer, J; Schubert, K; Wagner, H; Wesemann, R1
Hieu, DK; Hobe, G; Reddersen, G; Wehrberger, K1
Jemilev, ZA; Komor, A; Schubert, K; Strecke, J1
Koch, M; Peschke, T; Stracke, R1
Lisse, K; Schürenkämper, P1
Freund, H; Freund, R; Kurischko, A; Meyer, M; Oettel, M; Stölzner, W1
Eychenne, B; Kaufmann, G; Schlegel, J; Schubert, K1
Becker, K; Braun, R; Schöneich, J1
Freund, H; Koch, M; Kurischko, A; Oettel, M; Römer, W; Stölzner, W; Stracke, R; Strecke, J1
Chemnitius, KH; Dietz, K; Freund, H; Hesse, G; Oettel, M; Raj, MH; Stölzner, W1
Härtl, A; Hillesheim, HG; Hoffmann, H; Kirchner, E; Knappe, H; Tkocz, R1
Hillesheim, HG; Hoffmann, H1
Anke, M; Chemnitius, KH; Dettmann, R; Deufrains, J; Furcht, R; Gaida, P; Güttner, J; Hesse, G; Hesse, V; Hillesheim, HG; Hoffmann, H; Holle, K; Horn, U; Keil, E; Klinger, G; Kramp, B; Lemke, H; Merbt, EM; Oettel, M; Robiller, F; Schimmel, I; Selzner, A; Stade, K; Strecke, J; Valentin, U1
Goncharov, NP; Komor, A; Oettel, M; Schubert, K1
Koch, M1
Göretzlehner, G; Köhler, G; Kunkel, S; Meissner, J; Rudolf, K; Rüting, M; Schollberg, K1
Bräuer, R; Chemnitius, KH; Grass, M1
Das, RP; Warikoo, PK1
Frankenberg, G; Hobe, G; Schade, W; Schön, R; Schubert, K1
Oettel, M; Ponsold, K; Schubert, K1
Hübner, M; Ponsold, K1
Carol, W; Chemnitius, KH; Claussen, C; Erdmann, A; Goncharov, NP; Hillesheim, HG; Hobe, G; Klinger, G; Komor, A; Ritter, P; Schumann, W; Wagner, H; Wehrberger, K; Wesemann, R1
Hobe, G; Hörhold, C; Kaufmann, G; Schubert, K; Schumann, G; Wehrberger, K1
Klaus, S1
Heinecke, H; Köhler, D1
Kaufmann, G; Schubert, K; Schumann, G1
Hesse, G; Kurischko, A; Löw, O; Oettel, M; Tkocz, H1
Jemilev, ZA; Komor, A; Oettel, M; Schubert, K; Strecke, J1
Güttner, J; Hillesheim, HG; Hoffmann, H; Oettel, M1
Goncharov, NP; Komor, A; Oettel, M1
Hillesheim, HG; Hoffmann, H; Oettel, M; Strecke, J1
Koch, M; Kurischko, A; Oettel, M; Strecke, J1
Hobe, G; Hörhold, C; Hübner, M; Schade, W; Schön, R; Schubert, K1
Castracane, VD; Goldzieher, JW1
Kurischko, A; Oettel, M1
Kaufmann, G; Kurischko, A; Oettel, M1
Aoki, D; Katsuki, Y; Nozawa, S; Shibutani, Y1
Aoki, D; Katsuki, Y; Nozawa, S; Sasagawa, S; Shibutani, Y; Takano, Y; Udagawa, Y1
Feichtinger, W; Gräser, T; Kindermann, C; Mellinger, U; Moore, C; Schneider, B; Spona, J; Walter, F1
Feichtinger, W; Gräser, T; Kindermann, C; Mellinger, U; Moore, C; Spona, J; Walter, F1
Carol, W; Gräser, T; Klinger, G; Mellinger, U; Moore, C; Oettel, M; Schindler, AE; Winkler, UH1
Aoki, D; Futamura, Y; Katsuki, Y; Nozawa, S; Shibutani, Y; Takano, Y; Udagawa, Y1
Glusa, E; Gräser, T; Oettel, M; Wagner, S1
Eick, S; Gräser, T; Klinger, G; Moore, C; Oettel, M; Pfister, W1
Hamada, Y; Ishikawa, T; Katsuki, Y; Nobukata, H; Sato, M; Shibutani, Y1
Foster, RH; Wilde, MI1
Inokuma, M; Ishikawa, T; Katsuki, Y; Nobukata, H; Shibutani, Y1
Chakravarty, S; Singh, SK1
Christensen, B; Henkel, A; Schindler, AE1
Dautzenberg, H; Henkel, H; Kaufmann, G; Müller, G; Oettel, M; Schäfer, T; Undeutsch, B1
Dietrich, H; Hoffmann, H; Wisser, KH; Zimmermann, T1
Katsuki, Y; Nakamura, M; Oikawa, T; Shibutani, Y1
Gräser, T; Groh, A; Klinger, G; Latterman, C; Mellinger, U; Moore, C; Vogelsang, H1
Gräser, T; Lippert, TH; Mellinger, U; Mück, AO; Müller, A; Oettel, M1
Glänzer, S; Klinger, G; Römer, W; Sigusch, B1
Hamada, Y; Inoue, S; Ishikawa, T; Kakinuma, C; Kuwayama, C; Shibutani, Y1
Kowald, A; Ortmann, J; Rabe, T; Rehberger-Schneider, S1
Balogh, A; Gräser, G; Kauf, E; Klinger, G; Oettel, M; Vollanth, R1
Kanzaki, H; Nakajima, T; Okada, H; Yasuda, K; Yoshimura, T1
Böck, G; Gräser, T; Gruber, D; Grünberger, J; Huber, J; Linzmayer, L; Metka, M; Oettel, M; Saletu, B; Saletu-Zyhlarz, G; Semlitsch, HV; Zoghlami, A1
Hobe, G; Jäger, R; Klinger, G; Küntzel, B; Piater, T; Schön, R1
Gräser, T; Lüdtke, R; Mueck, AO; Seeger, H; Wallwiener, D1
Skouby, SO1
Schneider, HP1
Drapier-Faure, E; Faure, M1
Fiegler, P; Kamiński, K; Marr, J; Moore, C1
Fiegler, P; Gabryś, J; Kamiński, K; Kozielski, J1
Meczekalski, B; Słopień, R; Warenik-Szymankiewicz, A1
Gräser, T; Lippert, TH; Mueck, AO; Oettel, M; Seeger, H1
Gräser, T; Janaud, A; Römer, T; Wiedey, KD1
Gräser, T; Koytchev, R; Müller, A; Oettel, M1
Bauer, HH; Gross, W; Kuhl, H; Kutschera, E; Lee, JH; Mellinger, U; Moore, C; von Hayn, C; Wiegratz, I; Winkler, UH1
Audebert, A; Cosson, M; Donnez, J; Konincks, P; Madelenat, P; Manhes, H; Querleu, D1
Bertaccini, A; Bremner, WJ; Costantino, A; Flamigni, C; Huebler, D; Kaufmann, G; Meriggiola, MC; Morselli-Labate, AM; Oettel, M1
Domschke, W; Heinig, J; Lerch, MM; Simon, P; Weiss, FU; Zimmer, KP1
Honjo, H; Hosoda, T; Kitawaki, J; Tanaka, K; Tatsumi, H1
Mueck, AO; Seeger, H; Wallwiener, D2
Anderer, P; Gruber, D; Huber, J; Metka, M; Saletu, B; Saletu-Zyhlarz, GM1
Kuhl, H; Kutschera, E; Lee, JH; Mellinger, U; Moore, C; Wiegratz, I; Winkler, UH2
Anderer, P; Gräser, T; Gruber, D; Huber, J; Metka, M; Oettel, M; Saletu, B; Saletu-Zyhlarz, G; Semlitsch, HV1
Rabe, T; Raudrant, D1
Domhardt, R; Golbs, S; Kałuzny, Z; Radowicky, S; Wisser, KH; Zimmermann, T1
Domhardt, R; Ganev, M; Golbs, S; Presl, J; Wisser, KH; Zimmermann, T1
Breckwoldt, M1
Kamischke, A; Nieschlag, E; Zitzmann, M1
Sitruk-Ware, R1
Teichmann, A1
von Schoultz, B1
Saletu, B1
Borakowska, B; Radowicki, S; Skórzewska, K1
Hommel, HH; Kuhl, H; Wiegratz, I; Zimmermann, T1
Azavedo, E; Carlström, K; Conner, P; Gräser, T; Söderqvist, G; Svane, G; von Schoultz, B; Walter, F1
Kuhl, H; Kutschera, E; Lee, JH; Wiegratz, I; Winkler, UH1
Brambilla, G; Carrozzino, R; Garbero, C; Gosmar, M; Manfredi, V; Martelli, A; Mattioli, F1
Breitbarth, H; Gräser, T; Kirsch, B; Mellinger, U; Palombo-Kinne, E; Rudolph, I1
Fushiki, S; Hirasugi, Y; Honjo, H; Hosoda, T; Iwasa, K; Kawata, M; Kikuchi, N; Kitawaki, J; Mihara, M; Oida, N; Tatsumi, H; Yamamoto, H1
Costantino, A; De Lasio, R; Gambineri, A; Meriggiola, MC; Pagotto, U; Pasquali, R; Patton, L; Pelusi, C; Pelusi, G1
Godekmerdan, A; Kumru, S; Kutlu, S; Yildiz, MF1
Aygun, E; Dansuk, R; Kucukercan, I; Pirimoglu, ZM; Turan, C; Unal, O1
Christensen, B; Henkel, A; Moore, C; Oettel, M; Schindler, AE2
Dietrich, H; Kuhl, H; Mittmann, K; Wiegratz, I; Zimmermann, T1
Atasaral, T; Baltaci, D; Bozkaya, H; Osmanağaoğlu, MA1
Fu, L; Hirata, T; Hirota, Y; Morimoto, C; Osuga, Y; Taketani, Y; Yano, T1
Endrikat, J; Graeser, T; Kunz, M; Lange, E; Schmidt, W1
Endrikat, J; Ertan, K; Graeser, T; Holz, C; Mellinger, U1
Emons, G; Faber, M; Günthert, AR; Hellriegel, S; Knappe, G1
Imada, K; Kami, H; Kato, S; Mita, S; Mizuguchi, K; Sasagawa, S; Shimizu, Y; Takeuchi, T1
Kuhl, H; Lange, E; Manthey, T; Mellinger, U; Mittmann, K; Sänger, N; Stahlberg, S; Wiegratz, I2
Baskan, B; Demir, B; Haberal, A; Kandemir, O; Karabulut, E; Ozturkoglu, E; Solaroglu, A1
Aso, T; Fukunaga, M; Hagino, H; Harada, T; Momoeda, M; Taketani, Y; Terakawa, N2
Duijkers, I; Endrikat, J; Klipping, C; Parke, S; Schmidt, W; Trummer, D1
Imada, K; Mizuguchi, K; Nagaoka, T; Sasagawa, S; Shimizu, Y; Tokado, H1
Imada, K; Mizuguchi, K; Sasagawa, S; Shimizu, Y1
Gräser, T; Palombo-Kinne, E; Schellschmidt, I; Schumacher, U1
Chaki, SP; Kaushik, MC; Misro, MM; Nandan, D1
Inoue, M; Kiyono, T; Kyo, S; Mita, S; Mizuguchi, K; Shimizu, Y; Takeuchi, T1
Blode, H; Lu, M; Morrison, D; Uddin, A; Zeiler, B; Zeun, S1
Bühling, KJ; Mueck, AO; Seeger, H1
Hoy, SM; Scott, LJ1
Faustmann, TA; Gerlinger, C; Köhler, G; Mueck, AO; Seitz, C1
Bitzer, J; Machlitt, A; Palacios, S; Parke, S; Römer, T; Wildt, L1
Harada, T; Taniguchi, F1
Kuhl, H; Lange, E; Manthey, T; Mellinger, U; Mittmann, K; Palombo-Kinne, E; Sänger, N; Stahlberg, S; Wiegratz, I3
Henkel, A; Moore, C; Oettel, M; Schindler, AE1
Kitawaki, J1
Faustmann, T; Gerlinger, C; Marr, J; Seitz, C; Strowitzki, T2
Alsina, JC1
Pérez-Campos, EF1
Faustmann, T; Gerlinger, C; Seitz, C; Strowitzki, T1
Assmann, A; Dinger, J; Minh, TD; Möhner, S1
Hiratsuka, M; Ito, M; Katayama, H; Katayama, T; Kiyomura, M; Shimizu, Y; Sugita, A; Uematsu, K1
Kyo, S; Mita, S; Mizuguchi, K; Notsu, T; Shimizu, Y; Takeuchi, T1
Iwen, A; Lehnert, H1
McCormack, PL1
Ichigo, S; Imai, A; Matsunami, K; Suzuki, N; Takagi, H1
Harada, M; Hirata, T; Izumi, G; Koga, K; Osuga, Y; Takamura, M; Takemura, Y; Taketani, Y; Yano, T; Yoshino, O1
Keder, LM1
Drife, JO1
Fraser, IS; Jensen, JT; Machlitt, A; Mellinger, U; Parke, S1
Kitawaki, J; Kusuki, I; Suganuma, I; Yamanaka, K1
Duijkers, I; Junge, W; Klipping, C; Mellinger, U; Parke, S; Serrani, M1
Faustmann, T; Gerlinger, C; Hornung, D; Lazzeri, L; Luisi, S; Petraglia, F; Seitz, C; Strowitzki, T1
Fraser, IS; Jensen, J; Machlitt, A; Mellinger, U; Parke, S; Serrani, M1
Fraser, IS; Jensen, JT; Machlitt, A; Mellinger, U; Parke, S; Römer, T; Zeun, S1
Ichigo, S; Imai, A; Matsunami, K; Takagi, H1
Jensen, JT; Micks, E1
Fischer, OM; Fuhrmann, U; Kaufmann-Reiche, U; Moeller, C1
Imada, K; Kyo, S; Mita, S; Notsu, T; Shimizu, Y1
Ghosh, D; Meena, R; Misro, MM; Nandan, D2
Helmerhorst, FM; Lopez, LM; Raps, M; Van Vliet, HA1
Duijkers, I; Faustmann, T; Klein, S; Klipping, C; Remmers, A; Schuett, B; Zurth, C1
Kitawaki, J; Kusuki, I; Mita, S; Mizuguchi, K; Shimizu, Y; Suganuma, I; Xu, B; Yamanaka, K1
Nappi, RE1
Mueck, AO; Ruan, X; Seeger, H1
Aoki, D; Banno, K; Kisu, I; Kobayashi, Y; Masuda, K; Nomura, H; Susumu, N; Tsuji, K; Ueki, A; Yamagami, W; Yanokura, M1
Morikawa, A; Nagata, C; Ochiai, K; Okamoto, A; Okamoto, S; Sugimoto, K; Tanaka, T; Yanagida, S1
Bitzer, J; Fruzzetti, F; Trémollieres, F1
Faustmann, T; Gerlinger, C; Hassall, JJ; Seitz, C1
Beranič, N; Rižner, TL1
Duijkers, I; Endrikat, J; Klipping, C; Parke, S; Serrani, M; Trummer, D1
Chaya, J; Hayashi, K; Kato, N; Nishino, K; Yamamuro, O1
Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H1
Beranič, N; Lanišnik Rižner, T1
Ghosh, D; Meena, R; Misro, MM1
Jang, IJ; Lee, S; Lim, KS; Park, JS; Shin, D; Shin, SG; Yu, KS1
Ballieux, B; Helmerhorst, F; Raps, M; Rosendaal, F; Rosing, J; Thomassen, S; van Vliet, H1
Martini, E; Nappi, RE; Sances, G; Santamaria, V; Spinillo, A; Tassorelli, C; Terreno, E; Tonani, S1
Calagna, G; Colacurci, N; Cucinella, G; De Franciscis, P; Granese, R; Perino, A; Saitta, S; Svelato, A; Tonni, G1
De Leo, V; Di Sabatino, A; Fruzzetti, F; Morgante, G; Musacchio, MC; Scolaro, V1
Bifulco, G; Di Carlo, C; Gargano, V; Nappi, C; Schettino, D; Sparice, S; Tommaselli, GA1
Macìas, G; Mellinger, U; Merki-Feld, GS; Parke, S; Serrani, M1
Bifulco, G; Di Carlo, C; Gargano, V; Nappi, C; Sparice, S; Tommaselli, GA1
Bitzer, J; Davis, SR; Giraldi, A; Mellinger, U; Nappi, RE; Palacios, S; Parke, S; Serrani, M1
Akita, M; Brosens, JJ; Fujita, K; Ishihara, O; Kajihara, T; Matsumoto, S; Nagashima, M; Prechapanich, J; Sato, K; Tanaka, K; Uchino, S1
Imada, K; Kyo, S; Mita, S; Notsu, T; Sato, A; Shimizu, Y1
Schindler, AE1
Avraham, S; Seidman, DS1
Fukaya, T; Izumiya, C; Maeda, N; Matsushima, S; Mita, S; Shimizu, Y; Taniguchi, K1
Fujii, T; Harada, M; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Miyashita, M; Nagai, M; Osuga, Y; Takamura, M1
Iwasaki, M; Matsuura, M; Saito, T; Tabuchi, Y; Takada, S; Tamate, M; Tanaka, R1
Bannemerschult, R; Endrikat, J; Gerlinger, C; Marr, J; Mellinger, U; Merz, M; Schellschmidt, I; Trussell, J1
Batta, N; Pallapothu, LM; Pigili, RK; Yejella, RP1
Fujii, T; Harada, M; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Nakazawa, A; Osuga, Y; Saito, A; Takamura, M1
Cagnacci, A; Grandi, G; Piacenti, I; Volpe, A1
Kimura, F; Kishi, Y; Murakami, T; Shimizu, Y; Suginami, H; Takahashi, K; Yamanaka, A1
Kurabayashi, T; Tamura, M; Tsuneki, I; Yanase, T1
Bizzarri, N; Candiani, M; Ferrero, S; Ghirardi, V; Leone Roberti Maggiore, U; Remorgida, V; Salvatore, S; Scala, C; Tafi, E; Venturini, PL1
Guvenal, T; Hasdemir, PS; Ikiz, N; Kara, E; Ozcakir, HT1
Ferrero, S; Leone Roberti Maggiore, U; Salvatore, S1
Hayashi, A; Hayashi, M; Kyo, S; Ohmichi, M; Ono, YJ; Tanabe, A; Terai, Y; Yamashita, Y1
Agarwal, S; Chen, I; Fraser, MA; Singh, SS1
De Rosa, N; Di Carlo, C; Gargano, V; Nappi, C; Sparice, S; Tommaselli, GA1
Fukuda, S; Hattori, K; Orisaka, M; Tsang, BK; Tsuyoshi, H; Yoshida, Y1
Ferrero, S; Morotti, M; Remorgida, V; Sozzi, F; Venturini, PL1
Bono, Y; Ichioka, M; Imada, K; Kiyono, T; Kyo, S; Mita, S; Shimizu, Y1
Andres, Mde P; Baracat, EC; Lopes, LA; Podgaec, S1
Ito, F; Kitawaki, J; Koshiba, A; Kusuki, I; Matsushima, H; Mori, T; Takaoka, O; Tanaka, Y1
Angioni, S; Luisi, S; Mais, V; Melis, GB; Nappi, L; Pontis, A; Sedda, F1
Hatano, K; Hiraku, Y; Morishige, K; Sato, K; Shibata, M; Takenaka, M; Yamamoto, K; Yamamoto, S; Yano, R1
Fawzy, M; Mesbah, Y1
Choi, D; Choi, J; Jo, M; Lee, DY; Lee, E2
Bizzarri, N; Ferrero, S; Remorgida, V; Venturini, PL1
Ishida, M; Kurabayashi, T; Morikawa, K; Nishijima, S; Takaki, Y; Tamura, M; Tsuneki, I; Yanase, T; Yokoo, T1
Caruso, S; Casella, E; Cianci, A; Cianci, S; Fava, V; Iraci, M2
Hayashi, H; Nagata, C; Okamoto, A; Sugimoto, K; Yanagida, S1
Nelson, AL1
Bersinger, NA; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Volpe, A1
Alberico, D; Bracco, B; Dhouha, D; Mosconi, P; Roberto, A; Somigliana, E; Vercellini, P1
Honda, R; Katabuchi, H; Ohba, T; Saito, F; Suzuki, A; Tashiro, H; Yamaguchi, M1
Ban Frangež, H; Giacobbe, V; Granese, R; Ietto, C; Laganà, AS; Palmara, VI; Triolo, O; Vrtačnik-Bokal, E1
Adachi, K; Fujitani, M; Kimura, T; Kobayashi, E; Miyoshi, Y; Nakamura, K; Otake, A; Sasamoto, N; Sawada, K; Shioji, M; Takahashi, K; Tokuhira, A; Wakimoto, A; Yamamoto, Y; Yoshimura, A1
Apter, D; Beekman, L; Coelingh Bennink, HJ; Foidart, JM; Maillard, C; Mawet, M; Zimmerman, Y1
Cagnacci, A; Grandi, G; Napolitano, A1
de la Viuda, E; Lete, I; Martínez, MÁ; Novalbos, J; Pérez-Campos, E; Sánchez-Borrego, R; Sanchez-de la Rosa, R1
Isaka, K; Kato, R; Kojima, J; Nagamitsu, Y; Nishi, H; Sasaki, T; Takaesu, Y1
Ani Amelia, Z; Chew, KT; Hing, EY; Nor Azlin, MI; Norsaadah, S; Nur Azurah, AG; Suraya, A1
Dinger, J; Do Minh, T; Heinemann, K1
Bersinger, N; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Nirgianakis, K1
Bersinger, N; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Nirgianakis, K; Papadia, A1
Choi, D; Lee, DY; Lee, JY; Seo, JW; Yoon, BK1
Fujii, T; Harada, M; Hirata, T; Hirota, Y; Koga, K; Makabe, T; Miyashita, M; Osuga, Y; Sue, F; Takeuchi, A1
Buscema, M; Frangež, HB; Giunta, L; Granese, R; Laganà, AS; Muscia, V; Palmara, V; Rapisarda, AM; Romano, A; Rossetti, P; Triolo, O; Vitale, SG1
Alfaraj, S; Allaire, C; Bedaiwy, MA1
Casper, RF1
Böttcher, B; Dong, L; Ebert, AD; Francuski, M; Gude, K; Hlavackova, O; Kirsch, B; Merz, M; Roman, H; Seitz, C; Suvitie, P1
Benetti-Pinto, CL; Cursino, K; Leonardo-Pinto, JP; Yela, DA1
Choi, D; Lee, DY; Seo, JW; Yoon, BK1
Bersinger, NA; Facchinetti, F; Grandi, G; McKinnon, BD; Mueller, MD1
Baldane, S; Celik, C; Dursunoglu, D; Ilhan, TT; Ipekci, SH; Kebapcilar, AG; Kebapcilar, L; Kirac, CO; Kurt, K; Ucar, MG1
Hashiba, M; Ichioka, M; Kyo, S; Mita, S; Miyazaki, H; Nakakuki, M; Shimizu, Y1
Ban Frangež, H; Chiofalo, B; Granese, R; Laganà, AS; Palmara, V; Triolo, O; Vitale, SG; Vrtačnik-Bokal, E1
Black, A; Chen, I; Hodge, MC; Lalani, S; Tulandi, T1
Alio, L; Alio, W; Giambanco, L; Incandela, D; Maiorana, A; Mercurio, A; Parazzini, F1
Acmaz, G; Akkaya, H; Cagli, F; Karakilic, EU; Madendag, I; Madendag, Y; Uysal, G1
Andou, M; Ebisawa, K; Hada, T; Kanno, K; Matsumoto, T; Nakajima, S; Ota, Y; Shirane, A; Yamanaka, A; Yanai, S1
Hagino, A; Osuga, Y; Watanabe, M1
Fujimoto-Okabe, H; Hagino, A; Osuga, Y1
Berg, SM; Cwiertny, DM; Gloer, JB; Hankard, MK; Kolodziej, EP; O'Connor, M; Pflug, NC; Wammer, KH1
Dong, L; Gude, K; Lang, J; Li, H; Ren, X; von Ludwig, C; Yu, Q; Zhang, S1
Arena, A; Caprara, G; Del Forno, S; Mabrouk, M; Matteucci, C; Paradisi, R; Seracchioli, R; Zannoni, L1
Cho, S; Kim, SH; Lee, DY; Lee, SR; Seo, SK; Song, JY; Yi, KW1
Aylamazyan, E; Gzgzyan, A; Kogan, I; Muller, V; Niauri, D; Yarmolinskaya, M1
Kamada, Y; Kotani, S; Masuyama, H; Sakamoto, A1
Chabbert-Buffet, N; Fernandez, H; Geoffron, S; Legendre, G; Sauvan, M; Wattier, JM1
Bouet, PE; Chabbert-Buffet, N; Delbos, L; Descamps, P; Fernandez, H; Geoffron, S; Hudon, E; Legendre, G; Sauvan, M1
Kimura, F; Mita, S; Morimune, A; Murakami, T; Niwa, Y; Takahashi, K; Wu, D; Zheng, L1
Cheung, CW; Fung, WY; Liang, B; Wang, CC; Wong, SW; Wu, L; Xu, H1
Caserta, D; Maniglio, P; Meli, F; Peiretti, M; Ricciardi, E; Tomao, F1
Jee, BC; Jeong, SH; Kim, SK; Lee, D1
Angerame Yela, D; Laguna Benetti-Pinto, C; Paulo Leonardo-Pinto, J1
Fujii, T; Fukuda, S; Harada, M; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Nakazawa, A; Neriishi, K; Osuga, Y; Wada-Hiraike, O; Yamamoto, N1
Cho, S; Kim, SH; Lee, DY; Lee, JH; Lee, SR; Seo, SK; Shin, JH; Song, JY; Yi, KW1
Han, HY; Jung, YW; Kang, BH; Ko, YB; Lee, KH; Lee, M; Song, SY; Yang, JB; Yoo, HJ1
Akiyama, K; Ito, F; Kataoka, H; Kitawaki, J; Koshiba, A; Kusuki, I; Matsushima, H; Mori, T; Okimura, H; Takaoka, O1
Mizunuma, H; Ota, K; Shiraishi, S; Takahashi, T1
Herrmann, J; Kochhar, PS; Markert, UR; Morales-Prieto, DM; Oettel, M; Osterwald, H; Schleussner, E1
Beckmann, MW; Boosz, A; Dittrich, R; Hoffmann, I; Lotz, L; Mueller, A; Oppelt, PG; Raffel, N; Weber, M1
Römer, T1
Roth, K; Schäfer, WR; Zahradnik, HP1
Hiramatsu, T; Hongo, K; Kazama, S; Kuriki, K; Kuroda, K; Tanaka, T; Watanabe, Y1
Ziegler, C1
Dong, L; Lang, J; Li, H; Ren, X; Wang, P; Yu, Q; Zhang, S; Zvolanek, M1
Awaga, Y; Hama, A; Hayashi, I; Matsuda, A; Natsume, T; Ogawa, S; Takamatsu, H; Yano, M1
Choi, D; Kim, SE; Lee, DY; Seo, JW; Yoon, BK1
Cwiertny, DM; Gloer, JB; Knutson, CJ; Martinović-Weigelt, D; Pflug, NC; Swenson, DC; Wammer, KH1
Cai, G; Gu, M; Li, X; Mueck, AO; Ruan, X; Wang, L; Zhao, Y1
Dashraath, P; Kailun, C; Li, M1
Ahlers, C; Banal-Silao, MJ; Hestiantoro, A; Kim, MR; Lee, BS; Ruey, S; Seong, SJ; Shin, SY; Techatraisak, K; Thaufik, S1
Arena, A; Del Forno, S; Giaquinto, I; Mabrouk, M; Mattioli, G; Paradisi, R; Seracchioli, R1
Angioni, S; Cela, V; Litta, P; Luisi, S; Malune, ME; Nappi, L; Pontis, A; Vignali, M1
Arakawa, T; Fujii, T; Fukuda, S; Harada, M; Hirata, T; Hirota, Y; Koga, K; Ma, S; Nagashima, N; Neriishi, K; Osuga, Y; Sun, H; Wada-Hiraike, O1
Bardhi, E; Boccia, SM; Musella, A; Palaia, I; Panici, PB; Pecorini, F1
Fujimoto, A; Honda, M; Isono, W; Matsuyama, R; Nishii, O; Saito, A; Tsuchiya, A; Tsuchiya, H1
Akira, S; Matsushima, T; Takeshita, T; Yoneyama, K1
Hayashi, K; Kanda, S; Osuga, Y3
Akinishi, M; Iwai, K; Kawaguchi, R; Kobayashi, H; Matsubara, S; Nagayasu, M; Niiro, E; Tanase, Y; Yamada, Y1
Hudeček, R; Papíková, Z; Szypulová, M; Ventruba, P1
Josaki, M; Kikuchi, H; Mihara, Y; Shinagawa, M; Shirafuta, Y; Sugino, N; Takasaki, A; Taketani, T; Tamura, H; Tamura, I; Yoshida, H1
Fukui, Y; Hashimoto, T; Hayashi, T; Hirota, Y; Ikemura, M; Inoue, S; Kawazu, M; Kiyono, T; Kojima, S; Mano, H; Muraoka, A; Oda, K; Osuga, Y; Osuka, S; Saito, T; Sakata, S; Taguchi, A; Takeuchi, K; Takeyama, R; Tanaka, T; Tanaka, Y; Terao, Y; Ueno, T; Yoshida, E1
Li, C; Li, F; Li, L; Li, N; Li, T; Xue, J1
Yunker, AC1
Cho, B; Cho, CH; Jeong, K; Kim, SH; Kim, TH; Kim, YS; Kwon, YS; Park, J; Park, SH; Roh, JW1
Angioni, S; Barbasetti Di Prun, A; Barbera, V; Belloni, GM; Pietropaolo, G; Pino, I; Vignali, M1
Biberoğlu, K; Leng, J; Mueller, MD; Murji, A; Römer, T; Vignali, M; Yarmolinskaya, M1
Becker, K; Faustmann, T; Gerlinger, C; Heinemann, K; Imthurn, B; Marions, L; Moehner, S1
Arffman, RK; Haverinen, A; Heikinheimo, O; Hiltunen, JK; Kangasniemi, MH; Komsi, EK; Luiro, K; Piltonen, TT; Tapanainen, JS1
Abdelhakim, AM; Ahmed, SA; AlAmodi, AA; Ali, AS; Ashour, K; El Kattan, EAM; Elsherbini, M; Fathi, M; Haggag, H; Keshta, NHA; Salah, DM; Samy, A; Shareef, MA; Shatat, HBAE; Sileem, SA; Taher, A1
Ikuma, S; Jinushi, M; Kawasaki, Y; Kitade, M; Kumakiri, J; Murakami, K; Ozaki, R1
Nickisch, K; Oettel, M; Zentel, HJ1
Agliati, L; Gasparri, ML; McKinnon, B; Mueller, MD; Nirgianakis, K; Vaineau, C1
Barra, F; Ferrero, S; Garzon, S; Ghezzi, F; Laganà, AS; Scala, C1
Ainsworth, AJ; Cope, AG; Stewart, EA1
Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US1
Iwami, N; Kamiya, H; Kawamata, M; Mizuuchi, M; Moriwaka, O; Ozawa, N; Watanabe, E; Yamamoto, T1
Fukutomi, T; Kobayashi, Y; Mita, S; Suzuki, A; Watanabe, M1
Choi, D; Kim, SE; Lee, DY; Lim, HH1
Ali, MK; Hassanin, AI; Yousef, AM; Youssef, AA1
Asano, R; Miyagi, E; Nagai, K; Nakamura, T; Ono, N; Sugo, Y1
Aygen, EM; Demirtas, E; Sahin, Y; Uludag, SZ1
Alkatout, I; Allahqoli, L; Ebrahimpour, M; Gitas, G; Hassanlouei, B; Mehdizadeh Kashi, A; Niakan, G1
Abdel-Rasheed, M; Abdullah, A; Hosni, M; Khairy, M; Khalifa, E; Mohammad, H1
Ceccarello, M; Ceccaroni, M; Clarizia, R; Donati, A; Ferrero, S; Liverani, S; Manzone, M; Roviglione, G1
Fukami, T; Matsushima, T; Shinmura, H; Takeshita, T1
Dai, Y; Duan, J; Ha, C; Huang, R; Huang, X; Liu, J; Qiu, Y; Shi, B; Xiao, D; Xuan, J1
Kim, KE; Kolodziej, EP; Lam, K; Tian, Z; Wang, R; Zhao, HN1
Lee, SM; Park, JK1
Huang, Y; Ji, M; Jiao, X; Li, J; Li, Q; Wang, G; Yuan, M1
Ebrahimpour, M; Mehdizadeh Kashi, A; Niakan, G; Rokhgireh, S1
Abbasi, S; Abu Musa, A; El Taha, L; Khalifeh, D; Khalil, A; Nassif, J1
Goto, M; Iwase, A; Kajiyama, H; Miyake, N; Murakami, M; Muraoka, A; Nakamura, T; Nakanishi, N; Osuka, S; Sonehara, R; Tanaka, H; Yabuki, A; Yoshihara, M; Yoshita, S1
Banal-Silao, MJ; Cai, L; Hestiantoro, A; Hidayat, ST; Kim, MR; Lee, BS; Seong, SJ; Shin, S; Soon, R; Techatraisak, K1
Engin-Ustun, Y; Ibanoglu, MC; Kıykac Altinbas, S; Kizilkaya, Y1
Duffy, JMN; Farquhar, CM; Hirsch, M1
Allahqoli, L; Ebrahimpour, M; Hassanlouei, B; Niakan, G1
Caruso, G; Caruso, S; Cianci, A; Cianci, S; Iraci Sareri, M; Panella, M1
Fukuda, H; Kubo, A; Kunisada, M; Yoshioka, A1
Choi, D; Choi, SH; Kim, SE; Lee, DY; Lim, HH1
Lu, J; Lu, P; Miao, J; Tang, J1
Chen, LH; Feng, M; Hsu, LT; Wu, HM1
Li, Z; Wang, L; Wang, X; Zhang, Z1
Kadirogullari, P; Seckin, KD1
Alfano, P; Audino, P; Incandela, D; Maiorana, A; Marcantonio, S; Mercurio, A; Minneci, G1
Li, X; Lin, J; Liu, Y; Zhang, L1
Akimoto, Y; Honda, H; Kaneko, M; Nishimichi, N; Tanimoto, H; Teramoto, H; Teramoto, M; Yamashita, M; Yokosaki, Y1
Bitoh, Y; Iwabuchi, S; Okata, Y; Samejima, Y; Tomioka, Y; Uemura, K; Watanabe, A; Yoshimura, S1
Tang, M; Yang, W; Zhang, H1
Hosseini, L; Hosseini, R; Rastad, H; Rodi, H; Vahid-Dastjerdi, M1
Abdeldayem, HM; Girbash, EF; Radwan, AM; Sherif, HE1
Dietrich, H; Imesch, P; Knobel, C; Merki-Feld, GS; Metzler, J; Muendane, A; Neumeier, MS; Niggli, A; Portmann, L1
Bogani, G; Carbone, F; Di Donato, V; Di Tucci, C; Galati, G; Kontopantelis, E; Muzii, L; Palaia, I; Perniola, G; Tomao, F1
Arena, A; Aru, AC; Borghese, G; Caroli, M; Casadio, P; Del Forno, S; Lenzi, J; Meriggiola, MC; Orsini, B; Paradisi, R; Raimondo, D; Seracchioli, R; Verrelli, L1
Guo, W; Hu, S; Lin, Y; Shen, Y1

Reviews

48 review(s) available for nandrolone and dienogest

ArticleYear
[New progestational hormones].
    Zentralblatt fur Gynakologie, 1988, Volume: 110, Issue:13

    Topics: Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Nandrolone; Norgestrel; Norpregnenes; Progesterone Congeners

1988
Dienogest.
    Drugs, 1998, Volume: 56, Issue:5

    Topics: Androgen Antagonists; Animals; Clinical Trials as Topic; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Nandrolone; Progestins

1998
The rationale for a wider range of progestogens.
    Climacteric : the journal of the International Menopause Society, 2000, Volume: 3 Suppl 2

    Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome

2000
The role of antiandrogens in hormone replacement therapy.
    Climacteric : the journal of the International Menopause Society, 2000, Volume: 3 Suppl 2

    Topics: Androgen Antagonists; Biological Availability; Body Weight; Chemistry, Pharmaceutical; Cognition; Coronary Disease; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Nandrolone; Osteoporosis, Postmenopausal; Patient Selection; Progesterone Congeners; Treatment Outcome

2000
[What is the role of hormonal treatments in acne?].
    Annales de dermatologie et de venereologie, 2001, Volume: 128 Supp 1

    Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone; Estrogens; Flutamide; Glucocorticoids; Hormone Antagonists; Humans; Mineralocorticoid Receptor Antagonists; Nandrolone; Patient Selection; Progestins; Spironolactone; Treatment Outcome

2001
Progestogens with antiandrogenic properties.
    Drugs, 2003, Volume: 63, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Animals; Chlormadinone Acetate; Clinical Trials as Topic; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Dermatitis, Seborrheic; Female; Hirsutism; Humans; Nandrolone; Progesterone Congeners; Progestins; Receptors, Androgen

2003
Use of progestins in male contraception.
    Steroids, 2003, Volume: 68, Issue:10-13

    Topics: Asian People; Contraception; Cyproterone Acetate; Desogestrel; Humans; Levonorgestrel; Male; Medroxyprogesterone; Nandrolone; Progestins; Steroids; Testosterone; Time Factors; White People

2003
Alternatives for optimal hormone replacement therapy.
    Climacteric : the journal of the International Menopause Society, 2003, Volume: 6 Suppl 2

    Topics: Chemistry, Pharmaceutical; Drug Delivery Systems; Estrogen Replacement Therapy; Female; Humans; Menopause; Nandrolone; Quality of Life; Women's Health

2003
Pharmacology of estradiol valerate/dienogest.
    Climacteric : the journal of the International Menopause Society, 2003, Volume: 6 Suppl 2

    Topics: Drug Administration Schedule; Drug Combinations; Endometrium; Estradiol; Female; Humans; Nandrolone

2003
Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment.
    Climacteric : the journal of the International Menopause Society, 2003, Volume: 6 Suppl 2

    Topics: Clinical Trials as Topic; Drug Combinations; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Nandrolone; Uterine Hemorrhage

2003
[Pharmacological and clinical profile of dienogest (DINAGEST Tab. 1 mg)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2009, Volume: 133, Issue:1

    Topics: Animals; Endometriosis; Female; Hormone Antagonists; Humans; Macaca mulatta; Mice; Nandrolone; Progesterone Congeners; Rabbits; Uterine Diseases

2009
Estradiol valerate/dienogest: in oral contraception.
    Drugs, 2009, Aug-20, Volume: 69, Issue:12

    Topics: Adolescent; Adult; Chemistry, Pharmaceutical; Contraceptives, Oral; Drug Combinations; Estradiol; Female; Humans; Middle Aged; Nandrolone; Pregnancy; Young Adult

2009
Dienogest: a new therapeutic agent for the treatment of endometriosis.
    Women's health (London, England), 2010, Volume: 6, Issue:1

    Topics: Animals; Dysmenorrhea; Endometriosis; Female; Hormone Antagonists; Humans; Male; Nandrolone; Ovary; Rabbits; Randomized Controlled Trials as Topic; Treatment Outcome; Uterine Hemorrhage

2010
[Maintenance therapy for endometriosis].
    Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68, Issue:1

    Topics: Clinical Trials as Topic; Contraceptives, Oral; Danazol; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Progesterone Congeners

2010
Ethinylestradiol/dienogest in oral contraception.
    Drugs, 2010, Apr-16, Volume: 70, Issue:6

    Topics: Animals; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Nandrolone

2010
Estradiol + dienogest. Oral contraception: estradiol does not provide a therapeutic advantage.
    Prescrire international, 2010, Volume: 19, Issue:106

    Topics: Contraceptives, Oral, Sequential; Drug Interactions; Estradiol; Female; Humans; Nandrolone

2010
What role for Qlaira in contraception?
    Drug and therapeutics bulletin, 2010, Volume: 48, Issue:9

    Topics: Adolescent; Adult; Contraceptives, Oral, Sequential; Drug Costs; Drug Interactions; Estradiol; Female; Humans; Middle Aged; Nandrolone; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Young Adult

2010
Dienogest: a review of its use in the treatment of endometriosis.
    Drugs, 2010, Nov-12, Volume: 70, Issue:16

    Topics: Animals; Endometriosis; Female; Humans; Nandrolone; Progestins

2010
A new estradiol-dienogest oral contraceptive marks "The Pill's" 50th anniversary.
    American journal of therapeutics, 2011, Volume: 18, Issue:1

    Topics: Adult; Chemistry, Pharmaceutical; Contraceptives, Oral, Hormonal; Drug Approval; Estradiol; Estrogens; Female; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Nandrolone; Progestins; United States; United States Food and Drug Administration

2011
Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2011, Volume: 16, Issue:4

    Topics: Adult; Contraceptives, Oral; Drug Combinations; Estradiol; Female; Humans; Intention to Treat Analysis; Iron; Menorrhagia; Menstrual Hygiene Products; Middle Aged; Nandrolone; Randomized Controlled Trials as Topic

2011
Quadriphasic versus monophasic oral contraceptives for contraception.
    The Cochrane database of systematic reviews, 2011, Nov-09, Issue:11

    Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medication Adherence; Menstruation; Nandrolone; Randomized Controlled Trials as Topic; Uterine Hemorrhage

2011
[Association of E2v/DNG as contraceptive choice for a better quality of life of women].
    Minerva ginecologica, 2012, Volume: 64, Issue:1

    Topics: Contraceptive Agents; Contraceptives, Oral, Combined; Estradiol; Female; Humans; Nandrolone; Quality of Life; Sexuality

2012
The pharmacology of dienogest.
    Maturitas, 2012, Volume: 71, Issue:4

    Topics: Contraceptives, Oral; Endometriosis; Endometrium; Female; Humans; Menstrual Cycle; Nandrolone; Progestins

2012
Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review).
    International journal of oncology, 2012, Volume: 40, Issue:6

    Topics: Animals; Antineoplastic Agents, Hormonal; Clinical Trials as Topic; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Humans; Nandrolone; Progestins

2012
An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2012, Volume: 28, Issue:5

    Topics: Contraceptives, Oral, Combined; Estradiol; Female; History, 20th Century; Humans; Nandrolone

2012
Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials.
    BMC women's health, 2012, Apr-19, Volume: 12

    Topics: Asian People; Buserelin; Endometriosis; Europe; Female; Hormone Antagonists; Humans; Japan; Leuprolide; Nandrolone; Treatment Outcome; White People

2012
The "newer" progestogens and postmenopausal hormone therapy (HRT).
    The Journal of steroid biochemistry and molecular biology, 2014, Volume: 142

    Topics: Androstenes; Estradiol; Female; Humans; Megestrol; Nandrolone; Norpregnadienes; Postmenopause; Progestins

2014
Dienogest in the treatment of endometriosis.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:13

    Topics: Administration, Oral; Clinical Trials as Topic; Endometriosis; Female; Humans; Nandrolone; Progestins

2014
Dienogest for the treatment of deep endometriosis: case report and literature review.
    The journal of obstetrics and gynaecology research, 2015, Volume: 41, Issue:2

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Urinary Bladder Diseases; Vaginal Diseases

2015
Dienogest in the treatment of endometriosis: systematic review.
    Archives of gynecology and obstetrics, 2015, Volume: 292, Issue:3

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Progestins; Treatment Outcome

2015
Endometriosis: the effects of dienogest.
    BMJ clinical evidence, 2015, Jun-09, Volume: 2015

    Topics: Endometriosis; Female; Humans; Nandrolone

2015
An update on new orally administered contraceptives for women.
    Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:18

    Topics: Clinical Trials as Topic; Contraceptives, Oral; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Megestrol; Nandrolone; Norpregnadienes; Progestins

2015
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2016, Volume: 65, Issue:3

    Topics: Animals; Cytokines; Endometriosis; Epithelial Cells; Female; Hormone Antagonists; Humans; Immunologic Factors; Intercellular Signaling Peptides and Proteins; Nandrolone; Prostaglandins; Stromal Cells

2016
Metabolic impact of combined hormonal contraceptives containing estradiol.
    Expert opinion on drug metabolism & toxicology, 2016, Volume: 12, Issue:7

    Topics: Blood Pressure; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Hemostasis; Humans; Lipid Metabolism; Megestrol; Nandrolone; Norpregnadienes

2016
Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review.
    Archives of gynecology and obstetrics, 2017, Volume: 295, Issue:3

    Topics: Endometrium; Female; Humans; Hysteroscopy; Nandrolone

2017
Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy.
    Fertility and sterility, 2017, Volume: 107, Issue:3

    Topics: Adolescent; Adult; Age Factors; Contraceptives, Oral, Combined; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Medication Adherence; Nandrolone; Pelvic Pain; Progestins; Recurrence; Treatment Outcome; Young Adult

2017
Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills.
    Fertility and sterility, 2017, Volume: 107, Issue:3

    Topics: Administration, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Endometriosis; Endometrium; Female; Humans; Menstrual Cycle; Nandrolone; Norethindrone; Norethindrone Acetate; Pelvic Pain; Progestins; Treatment Outcome

2017
Dienogest Therapy as a Treatment for Catamenial Pneumothorax: Case Report and Review of Hormonal Options.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2017, Volume: 39, Issue:9

    Topics: Adult; Female; Hormone Antagonists; Humans; Leuprolide; Nandrolone; Pneumothorax

2017
[Management of painful endometriosis in adolescents: CNGOF-HAS Endometriosis Guidelines].
    Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:3

    Topics: Adolescent; Contraceptives, Oral; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Pelvic Pain

2018
[New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].
    Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:3

    Topics: Aromatase Inhibitors; Contraceptives, Oral; Dyspareunia; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Nandrolone; Pelvic Pain; Selective Estrogen Receptor Modulators

2018
Use of dienogest in endometriosis: a narrative literature review and expert commentary.
    Current medical research and opinion, 2020, Volume: 36, Issue:5

    Topics: Bone Density; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone

2020
Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials.
    Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:1

    Topics: Contraceptive Agents, Hormonal; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocarbons, Fluorinated; Levonorgestrel; Nandrolone; Network Meta-Analysis; Pelvic Pain; Pyrimidines; Randomized Controlled Trials as Topic; Visual Analog Scale

2021
A progestin isn't a progestin: dienogest for endometriosis as a blueprint for future research - Review as a contribution for discussion.
    Hormone molecular biology and clinical investigation, 2020, Jul-15, Volume: 42, Issue:2

    Topics: Clinical Decision-Making; Contraceptives, Oral, Hormonal; Disease Management; Endometriosis; Female; Humans; Nandrolone; Progestins; Structure-Activity Relationship; Treatment Outcome

2020
Current and Future Medical Therapies for Adenomyosis.
    Seminars in reproductive medicine, 2020, Volume: 38, Issue:2-03

    Topics: Adenomyosis; Dysmenorrhea; Female; Hormone Antagonists; Humans; Levonorgestrel; Menorrhagia; Nandrolone; Pain Measurement; Quality of Life

2020
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
    The Cochrane database of systematic reviews, 2020, 11-23, Volume: 11

    Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms

2020
Segmented in vitro fertilization and frozen embryo transfer in dienogest-treated patient with adenomyosis: A case report and lierature review.
    Taiwanese journal of obstetrics & gynecology, 2022, Volume: 61, Issue:5

    Topics: Adenomyosis; Adult; Embryo Transfer; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Nandrolone; Pregnancy

2022
Pretreatment of Dienogest for Women with Endometriosis in in vitro Fertilization: A Systematic Review and Meta-Analysis.
    Gynecologic and obstetric investigation, 2023, Volume: 88, Issue:3

    Topics: Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Ovulation Induction; Pregnancy; Pregnancy Rate

2023
The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis.
    Reproductive sciences (Thousand Oaks, Calif.), 2023, Volume: 30, Issue:11

    Topics: Cysts; Endometriosis; Female; Hot Flashes; Humans; Nandrolone; Pelvic Pain; Progestins

2023

Trials

93 trial(s) available for nandrolone and dienogest

ArticleYear
[Steroid receptors in the gestagen treatment of endometriosis].
    Therapeutische Umschau. Revue therapeutique, 1990, Volume: 47, Issue:12

    Topics: Adult; Endometriosis; Female; Humans; Nandrolone; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms

1990
[Postcoital contraception with dienogest].
    Zentralblatt fur Gynakologie, 1987, Volume: 109, Issue:21

    Topics: Adult; Clinical Trials as Topic; Contraceptives, Postcoital; Contraceptives, Postcoital, Hormonal; Female; Humans; Menstrual Cycle; Middle Aged; Nandrolone; Pregnancy

1987
Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
    Contraception, 1997, Volume: 56, Issue:2

    Topics: Adult; Antithrombin III; Blood Coagulation; Contraceptives, Oral; Double-Blind Method; Ethinyl Estradiol; Factor VII; Female; Fibrin; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Nandrolone; Peptide Fragments; Placebos; Plasminogen; Protein C; Prothrombin; Tissue Plasminogen Activator

1997
Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
    Contraception, 1997, Volume: 56, Issue:3

    Topics: Adult; Contraceptives, Oral; Endometrium; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Nandrolone; Ovarian Follicle; Ovulation; Progesterone; Ultrasonography

1997
[Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
    Zentralblatt fur Gynakologie, 1997, Volume: 119, Issue:12

    Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Nandrolone; Sex Hormone-Binding Globulin

1997
Influence of hormonal contraceptives on microbial flora of gingival sulcus.
    Contraception, 1998, Volume: 57, Issue:6

    Topics: Adult; Aggregatibacter actinomycetemcomitans; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gingiva; Humans; Nandrolone; Porphyromonas gingivalis; Prevotella intermedia

1998
A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2000, Volume: 14, Issue:1

    Topics: Adolescent; Adult; CD4 Lymphocyte Count; Contraceptives, Oral; Desogestrel; Female; Humans; Immunity; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Interleukin-6; Leukocyte Count; Menstrual Cycle; Nandrolone

2000
Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest - a dose-ranging study.
    Maturitas, 2000, Jun-30, Volume: 35, Issue:3

    Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Germany; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Nandrolone; Progesterone Congeners

2000
Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH).
    Contraception, 2000, Volume: 62, Issue:5

    Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Human Growth Hormone; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Levonorgestrel; Linear Models; Nandrolone; Time Factors

2000
Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
    Arzneimittel-Forschung, 2001, Volume: 51, Issue:3

    Topics: Affect; Arousal; Cognition; Double-Blind Method; Drug Combinations; Electroencephalography; Estradiol; Estrogens; Evoked Potentials; Female; Humans; Menopause; Middle Aged; Nandrolone; Personality; Progestins; Psychometrics; Psychomotor Performance; Pupil; Sleep

2001
Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest.
    Maturitas, 2001, May-30, Volume: 38, Issue:3

    Topics: Administration, Oral; Atrial Natriuretic Factor; Biomarkers; Cardiovascular Diseases; Cyclic GMP; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Nandrolone; Peptide Fragments; Postmenopause; Prospective Studies; Serotonin; Vasodilation

2001
[Treatment of endometriosis with dienogest: preliminary report].
    Ginekologia polska, 2001, Volume: 72, Issue:5

    Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Nandrolone; Pelvic Inflammatory Disease; Severity of Illness Index; Treatment Outcome

2001
Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.
    Climacteric : the journal of the International Menopause Society, 2001, Volume: 4, Issue:4

    Topics: Aged; Bone Resorption; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Endometrium; Estradiol; Europe; Female; Follicle Stimulating Hormone; Hormone Replacement Therapy; Hot Flashes; Humans; Lipoproteins; Middle Aged; Nandrolone; Patient Satisfaction; Postmenopause; Triglycerides; Ultrasonography; Uterine Hemorrhage

2001
Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women.
    Climacteric : the journal of the International Menopause Society, 2000, Volume: 3, Issue:2

    Topics: Biopsy; Breast Diseases; Double-Blind Method; Drug Combinations; Endometrial Hyperplasia; Endometrium; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Nandrolone; Norethindrone; Postmenopause; Prospective Studies; Therapeutic Equivalency; Treatment Outcome; Uterine Hemorrhage

2000
Effect of dienogest-containing oral contraceptives on lipid metabolism.
    Contraception, 2002, Volume: 65, Issue:3

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Nandrolone; Statistics, Nonparametric

2002
Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.
    Fertility and sterility, 2002, Volume: 77, Issue:4

    Topics: Adolescent; Adult; Alkaline Phosphatase; Cholesterol; Cholesterol, HDL; Combined Modality Therapy; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Triptorelin Pamoate

2002
Twenty-one day administration of dienogest reversibly suppresses gonadotropins and testosterone in normal men.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:5

    Topics: Adult; Contraceptive Agents, Male; Drug Administration Schedule; Gonadotropins; Hormones; Humans; Male; Nandrolone; Penile Erection; Reference Values; Spermatogenesis; Testosterone

2002
Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients.
    Maturitas, 2002, Nov-20, Volume: 43, Issue:3

    Topics: Aged; Arousal; Brain Mapping; Double-Blind Method; Drug Administration Schedule; Electroencephalography; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nandrolone; Postmenopause; Sleep Wake Disorders; Syndrome; Treatment Outcome

2002
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
    Contraception, 2003, Volume: 67, Issue:1

    Topics: Adolescent; Adult; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Levonorgestrel; Nandrolone; Reference Values; Sex Hormone-Binding Globulin; Testosterone; Thyroxine-Binding Proteins; Treatment Outcome

2003
Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia.
    Psychoneuroendocrinology, 2003, Volume: 28, Issue:3

    Topics: Affect; Aged; Double-Blind Method; Drug Combinations; Electrophysiology; Estradiol; Event-Related Potentials, P300; Evoked Potentials, Auditory; Female; Hormone Replacement Therapy; Humans; Middle Aged; Nandrolone; Neuropsychological Tests; Postmenopause; Progesterone Congeners; Reaction Time; Sleep Initiation and Maintenance Disorders

2003
Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland.
    Methods and findings in experimental and clinical pharmacology, 2002, Volume: 24, Issue:9

    Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hair; Humans; Nandrolone; Prospective Studies; Skin

2002
Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.
    Contraception, 2003, Volume: 67, Issue:5

    Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Contraceptives, Oral, Combined; Double-Blind Method; Drug Administration Schedule; Endothelin-1; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Nandrolone; Thyroid Hormones; Treatment Outcome

2003
Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
    Climacteric : the journal of the International Menopause Society, 2003, Volume: 6 Suppl 2

    Topics: Aged; Arousal; Cognition; Drug Therapy, Combination; Electrocardiography; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nandrolone; Postmenopause; Sleep Wake Disorders; Surveys and Questionnaires; Treatment Outcome

2003
[Influence of a new monophasic oral contraceptive on body metabolism].
    Ginekologia polska, 2003, Volume: 74, Issue:9

    Topics: Adolescent; Adult; Basal Metabolism; Cohort Studies; Contraception Behavior; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Humans; Nandrolone; Time Factors; Treatment Outcome

2003
Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy.
    Fertility and sterility, 2004, Volume: 81, Issue:6

    Topics: Breast; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Growth Substances; Hormones; Humans; Mammography; Nandrolone; Norethindrone; Norethindrone Acetate; Sex Hormone-Binding Globulin; Testosterone

2004
Effect of four oral contraceptives on hemostatic parameters.
    Contraception, 2004, Volume: 70, Issue:2

    Topics: alpha-2-Antiplasmin; Antithrombins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Estradiol; Ethinyl Estradiol; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Homeostasis; Humans; Levonorgestrel; Nandrolone; Peptide Fragments; Plasminogen; Plasminogen Inactivators; Protein C; Prothrombin; Tissue Plasminogen Activator

2004
Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression.
    Climacteric : the journal of the International Menopause Society, 2004, Volume: 7, Issue:3

    Topics: Depression; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nandrolone; Postmenopause; Psychiatric Status Rating Scales; Treatment Outcome

2004
Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2005, Volume: 90, Issue:2

    Topics: C-Reactive Protein; Cholesterol; Estradiol; Estrogen Replacement Therapy; Female; Glycine max; Humans; Isoflavones; Lipoproteins; Middle Aged; Nandrolone; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Treatment Outcome

2005
The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 21, Issue:3

    Topics: Adult; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Middle Aged; Nandrolone; Postmenopause; Treatment Outcome

2005
Fertility after discontinuation of treatment with an oral contraceptive containing 30 microg of ethinyl estradiol and 2 mg of dienogest.
    Fertility and sterility, 2006, Volume: 85, Issue:6

    Topics: Adult; Age Distribution; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Female; Fertility; Germany; Humans; Nandrolone; Outcome Assessment, Health Care; Pregnancy; Pregnancy Rate; Risk Assessment; Risk Factors; Treatment Outcome; Withholding Treatment

2006
Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
    Climacteric : the journal of the International Menopause Society, 2006, Volume: 9, Issue:6

    Topics: Arousal; Coitus; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hormone Antagonists; Humans; Libido; Middle Aged; Nandrolone; Norpregnenes; Patient Satisfaction; Postmenopause; Prospective Studies; Quality of Life; Sexual Dysfunction, Physiological; Single-Blind Method; Treatment Outcome

2006
A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2007, Volume: 12, Issue:3

    Topics: Aged; Bulgaria; Cholesterol, HDL; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Germany; Hemostasis; Humans; Hungary; Lipids; Middle Aged; Nandrolone; Poland; Postmenopause

2007
A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Maturitas, 2007, Oct-20, Volume: 58, Issue:2

    Topics: Administration, Oral; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Germany; Hot Flashes; Humans; Middle Aged; Nandrolone; Postmenopause; Prospective Studies; Severity of Illness Index; Treatment Outcome

2007
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
    Contraception, 2008, Volume: 77, Issue:6

    Topics: Adult; Androgens; Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Nandrolone; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Thyroid Hormones; Thyroxine-Binding Proteins

2008
The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2008, Volume: 24, Issue:6

    Topics: Blood Glucose; Carbohydrate Metabolism; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin Resistance; Lipid Metabolism; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Obesity; Progesterone Congeners; Prospective Studies

2008
Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial.
    Fertility and sterility, 2009, Volume: 91, Issue:3

    Topics: Abdominal Pain; Administration, Intranasal; Administration, Oral; Bone Density; Buserelin; Double-Blind Method; Dyspareunia; Endometriosis; Female; Humans; Japan; Low Back Pain; Nandrolone; Pain; Pain Measurement; Treatment Outcome

2009
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.
    Contraception, 2008, Volume: 78, Issue:3

    Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Female; Humans; Nandrolone; Ovulation Inhibition; Young Adult

2008
Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
    Contraception, 2008, Volume: 78, Issue:5

    Topics: Adolescent; Adult; Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Germany; Hemostasis; Humans; Nandrolone; Prospective Studies

2008
Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
    Contraception, 2009, Volume: 79, Issue:4

    Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral; Cyproterone Acetate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Middle Aged; Nandrolone; Young Adult

2009
Dienogest and the breast.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2009, Volume: 25, Issue:7

    Topics: Adult; Breast; Endometriosis; Female; Fibrocystic Breast Disease; Hormone Antagonists; Humans; Nandrolone; Pilot Projects; Ultrasonography, Mammary; Young Adult

2009
Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2009, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Carrier Proteins; Contraceptives, Oral; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Headache; Humans; Middle Aged; Nandrolone; Radioimmunoassay; Sex Hormone-Binding Globulin; Young Adult

2009
A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2010, Volume: 108, Issue:1

    Topics: Adult; Dose-Response Relationship, Drug; Endometriosis; Female; Fertility; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Statistics, Nonparametric; Treatment Outcome; Young Adult

2010
Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2010, Volume: 149, Issue:1

    Topics: Adolescent; Adult; Austria; Contraceptives, Oral, Combined; Drug Administration Schedule; Estradiol; Female; Germany; Humans; Middle Aged; Nandrolone; Patient Compliance; Patient Satisfaction; Spain; Surveys and Questionnaires; Treatment Outcome

2010
Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on lipid metabolism during 1 year of conventional or extended-cycle use.
    Contraception, 2010, Volume: 81, Issue:1

    Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Intention to Treat Analysis; Lipid Metabolism; Nandrolone; Patient Selection; Triglycerides

2010
Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis.
    Archives of gynecology and obstetrics, 2010, Volume: 282, Issue:5

    Topics: Adolescent; Adult; Antithrombin III; Cholesterol; Dose-Response Relationship, Drug; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Peptide Fragments; Pilot Projects; Protein C; Prothrombin; Surveys and Questionnaires; Young Adult

2010
Long-term use of dienogest for the treatment of endometriosis.
    The journal of obstetrics and gynaecology research, 2009, Volume: 35, Issue:6

    Topics: Adult; Bone Density; Endometriosis; Female; Hormone Antagonists; Humans; Longitudinal Studies; Middle Aged; Nandrolone; Prospective Studies; Young Adult

2009
Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.
    Human reproduction (Oxford, England), 2010, Volume: 25, Issue:3

    Topics: Adult; Bone Density; Endometriosis; Female; Humans; Leuprolide; Nandrolone; Pelvic Pain; Progestins; Quality of Life

2010
Effects of combined oral contraceptive ethinylestradiol (30 microg) and dienogest (2 mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2010, Volume: 42, Issue:5

    Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Menstruation; Nandrolone; Prospective Studies; Young Adult

2010
Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study.
    European journal of obstetrics, gynecology, and reproductive biology, 2010, Volume: 151, Issue:2

    Topics: Adolescent; Adult; Double-Blind Method; Endometriosis; Europe; Female; Humans; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Progesterone Congeners; Quality of Life; Surveys and Questionnaires; Young Adult

2010
Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial.
    Obstetrics and gynecology, 2011, Volume: 117, Issue:4

    Topics: Adult; Confidence Intervals; Contraceptives, Oral; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Female; Humans; Menorrhagia; Nandrolone; Patient Satisfaction; Quality of Life; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome

2011
Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
    European journal of obstetrics, gynecology, and reproductive biology, 2011, Volume: 157, Issue:2

    Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Time Factors; Treatment Outcome; Uterine Hemorrhage

2011
Hemostatic effects of a novel estradiol-based oral contraceptive: an open-label, randomized, crossover study of estradiol valerate/dienogest versus ethinylestradiol/levonorgestrel.
    Drugs in R&D, 2011, Volume: 11, Issue:2

    Topics: Activated Protein C Resistance; Adolescent; Adult; Antigens; Antithrombin III; Blood Pressure; Contraceptives, Oral, Hormonal; Cross-Over Studies; Drug Combinations; Estradiol; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Levonorgestrel; Middle Aged; Nandrolone; Patient Compliance; Peptide Fragments; Protein C; Protein Precursors; Protein S; Prothrombin; Sex Hormone-Binding Globulin; Young Adult

2011
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment.
    Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:1

    Topics: Adolescent; Adult; Drug Administration Schedule; Endometriosis; Female; Follow-Up Studies; Germany; Hormone Antagonists; Humans; Italy; Middle Aged; Nandrolone; Pelvic Pain; Ukraine; Young Adult

2012
Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy.
    Contraception, 2011, Volume: 84, Issue:2

    Topics: Adult; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Nandrolone; Patient Satisfaction; Prospective Studies; Young Adult

2011
Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial.
    Human reproduction (Oxford, England), 2011, Volume: 26, Issue:10

    Topics: Adult; Australia; Contraceptive Agents; Contraceptives, Oral; Double-Blind Method; Estradiol; Europe; Female; Humans; Menorrhagia; Menstruation; Menstruation Disturbances; Nandrolone; Placebos; Treatment Outcome

2011
Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women.
    Journal of clinical pharmacology, 2012, Volume: 52, Issue:11

    Topics: Adolescent; Adult; Contraceptives, Oral; Double-Blind Method; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Nandrolone; Ovarian Follicle; Ovulation; Young Adult

2012
Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2012, Volume: 117, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Dysmenorrhea; Endometriosis; Estrogens; Female; Humans; Leuprolide; Middle Aged; Nandrolone; Pelvic Pain; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Young Adult

2012
Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study.
    Contraception, 2013, Volume: 87, Issue:2

    Topics: Adolescent; Adult; Cervix Mucus; Contraceptives, Oral, Combined; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Nandrolone; Ovary; Ovulation; Pituitary Gland; Progesterone

2013
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Journal of thrombosis and haemostasis : JTH, 2013, Volume: 11, Issue:5

    Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Combined; Estradiol; Female; Humans; Nandrolone; Sex Hormone-Binding Globulin; Young Adult

2013
Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?
    Archives of gynecology and obstetrics, 2013, Volume: 288, Issue:4

    Topics: Adolescent; Adult; Combined Modality Therapy; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Endometriosis; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Laparoscopy; Nandrolone; Norpregnenes; Ovarian Diseases; Secondary Prevention; Treatment Outcome; Young Adult

2013
Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: results from the multicentre, randomised, double-blind, active-controlled HARMONY II study.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2013, Volume: 33, Issue:6

    Topics: Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Substance Withdrawal Syndrome; Young Adult

2013
Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
    The journal of sexual medicine, 2013, Volume: 10, Issue:12

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Drug Substitution; Estradiol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Nandrolone; Sexual Dysfunction, Physiological; Young Adult

2013
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.
    Contraception, 2014, Volume: 90, Issue:2

    Topics: Adult; Androstenes; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Europe; Female; Humans; Intention to Treat Analysis; Matched-Pair Analysis; Nandrolone; Norpregnenes; Pregnancy; Pregnancy, Unwanted; Progestins; Risk Assessment; South America; Transdermal Patch; United States; Young Adult

2014
Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment.
    European journal of obstetrics, gynecology, and reproductive biology, 2014, Volume: 183

    Topics: Adult; Contraceptives, Oral; Endometriosis; Female; Follow-Up Studies; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Pain Measurement; Patient Satisfaction; Pelvic Pain; Pilot Projects; Prospective Studies; Quality of Life; Rectal Diseases; Treatment Outcome; Vaginal Diseases

2014
Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:5

    Topics: Adult; Danazol; Female; Hormone Antagonists; Humans; Hysteroscopy; Leiomyoma; Nandrolone; Preoperative Care; Preoperative Period; Prospective Studies; Treatment Outcome; Uterine Neoplasms

2016
Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).
    Contraception, 2016, Volume: 94, Issue:4

    Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estetrol; Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Nandrolone

2016
Effect on quality of life of switching to combined oral contraception based on natural estrogen: an observational, multicentre, prospective phase IV study (ZOCAL Study).
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2016, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Condoms; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Megestrol; Metrorrhagia; Middle Aged; Nandrolone; Patient Satisfaction; Premenstrual Syndrome; Prospective Studies; Quality of Life; Young Adult

2016
Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis.
    The journal of obstetrics and gynaecology research, 2016, Volume: 42, Issue:9

    Topics: Adult; Conservative Treatment; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormone Antagonists; Humans; Nandrolone; Pain; Postoperative Care; Prospective Studies; Recurrence; Secondary Prevention

2016
The Efficacy of Dienogest in the Treatment of Simple Endometrial Hyperplasia without Atypia.
    Gynecologic and obstetric investigation, 2018, Volume: 83, Issue:2

    Topics: Adult; Endometrial Hyperplasia; Female; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Premenopause; Progesterone; Progestins; Prospective Studies

2018
Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study.
    Fertility and sterility, 2017, Volume: 108, Issue:4

    Topics: Adenomyosis; Adult; Double-Blind Method; Female; Humans; Japan; Menstruation Disturbances; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Placebos; Severity of Illness Index; Treatment Outcome; Young Adult

2017
Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study.
    Journal of women's health (2002), 2018, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Asian People; Bone Density; China; Double-Blind Method; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Progestins; Treatment Outcome; Young Adult

2018
Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:5

    Topics: Adult; Endometriosis; Endometrium; Female; Humans; Inflammation; Middle Aged; Nandrolone; Ovarian Diseases; Prospective Studies; Treatment Outcome; Young Adult

2018
Comparison of dienogest effects upon 3,3'-diindolylmethane supplementation in models of endometriosis and clinical cases.
    Reproductive biology, 2018, Volume: 18, Issue:3

    Topics: Cell Line; Cell Proliferation; Drug Therapy, Combination; Endometriosis; Endometrium; Female; Humans; Indoles; Nandrolone

2018
Dienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension Study.
    Journal of women's health (2002), 2019, Volume: 28, Issue:2

    Topics: Asian People; Bone Density; China; Double-Blind Method; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Treatment Outcome

2019
Evaluation of the efficacy, safety, and clinically recommended dose of dienogest in the treatment of primary dysmenorrhea: a randomized, double-blind, multicenter, placebo-controlled study.
    Fertility and sterility, 2020, Volume: 113, Issue:1

    Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Dysmenorrhea; Female; Hemorrhage; Hormone Antagonists; Humans; Nandrolone; Treatment Outcome

2020
The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis.
    Journal of ovarian research, 2019, Dec-12, Volume: 12, Issue:1

    Topics: Adult; Cytokines; Embryo Transfer; Endometriosis; Female; Fertilization in Vitro; Follicular Fluid; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Infertility, Female; Nandrolone; Oxidative Stress; Treatment Outcome

2019
Long-term use of dienogest for the treatment of primary and secondary dysmenorrhea.
    The journal of obstetrics and gynaecology research, 2020, Volume: 46, Issue:4

    Topics: Adult; Drug Administration Schedule; Dysmenorrhea; Female; Hormone Antagonists; Humans; Menstruation Disturbances; Nandrolone; Severity of Illness Index; Time Factors; Treatment Outcome; Uterine Hemorrhage

2020
Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study.
    Reproductive sciences (Thousand Oaks, Calif.), 2020, Volume: 27, Issue:3

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pain; Prospective Studies; Treatment Outcome

2020
A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea.
    Fertility and sterility, 2020, Volume: 113, Issue:3

    Topics: Administration, Oral; Adult; Back Pain; Dosage Forms; Double-Blind Method; Dysmenorrhea; Female; Humans; Japan; Nandrolone; Pain Measurement; Pelvic Pain; Placebos; Treatment Outcome; Young Adult

2020
Estradiol Valerate in COC Has More Favorable Inflammatory Profile Than Synthetic Ethinyl Estradiol: A Randomized Trial.
    The Journal of clinical endocrinology and metabolism, 2020, 07-01, Volume: 105, Issue:7

    Topics: Adult; C-Reactive Protein; Cholesterol; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Inflammation; Lipid Metabolism; Lipoproteins, LDL; Nandrolone; Serum Amyloid P-Component; Triglycerides; Young Adult

2020
Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2021, Volume: 154, Issue:2

    Topics: Adenomyosis; Adult; Contraceptives, Oral, Combined; Egypt; Female; Humans; Nandrolone; Pain Measurement; Uterine Hemorrhage

2021
A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 156, Issue:1

    Topics: Contraceptives, Oral, Combined; Endometriosis; Female; Humans; Nandrolone; Pilot Projects; Quality of Life

2022
Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial.
    BMC pregnancy and childbirth, 2021, Mar-30, Volume: 21, Issue:1

    Topics: Adult; Embryo Transfer; Endometriosis; Female; Humans; Infertility, Female; Leuprolide; Nandrolone; Ovulation Induction; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Treatment Outcome

2021
Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2021, Volume: 37, Issue:10

    Topics: Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intestines; Laparoscopy; Leuprolide; Nandrolone; Pelvic Pain; Peritoneum; Postoperative Care; Pregnancy; Recurrence; Reoperation; Secondary Prevention; Treatment Outcome; Triptorelin Pamoate

2021
Comparing the Effect of Dienogest and OCPS on Pain and Quality of Life in Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Archives of Iranian medicine, 2021, 09-01, Volume: 24, Issue:9

    Topics: Adult; Endometriosis; Female; Humans; Iran; Nandrolone; Pain Measurement; Pelvic Pain; Quality of Life; Treatment Outcome

2021
Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial.
    European journal of obstetrics, gynecology, and reproductive biology, 2021, Volume: 267

    Topics: Contraceptives, Oral, Combined; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Quality of Life; Retrospective Studies

2021
Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial.
    Reproductive biology and endocrinology : RB&E, 2021, Dec-06, Volume: 19, Issue:1

    Topics: Adult; Cystectomy; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Ovarian Reserve; Treatment Outcome; Urinary Bladder Diseases

2021
Re: A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 158, Issue:1

    Topics: Contraceptives, Oral, Combined; Double-Blind Method; Endometriosis; Female; Humans; Nandrolone; Pilot Projects

2022
Response: A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 158, Issue:1

    Topics: Contraceptives, Oral, Combined; Double-Blind Method; Endometriosis; Female; Humans; Nandrolone; Pilot Projects

2022
Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain.
    BMC women's health, 2022, 05-10, Volume: 22, Issue:1

    Topics: Chronic Pain; Contraceptives, Oral, Combined; Endometriosis; Estradiol; Female; Humans; Male; Megestrol; Nandrolone; Norpregnadienes; Pelvic Pain; Quality of Life

2022
Comparison of the effectiveness of Dienogest with medroxyprogesterone acetate in the treatment of pelvic pain and recurrence of endometriosis after laparoscopic surgery.
    Archives of gynecology and obstetrics, 2023, Volume: 308, Issue:1

    Topics: Endometriosis; Female; Humans; Laparoscopy; Medroxyprogesterone Acetate; Nandrolone; Pelvic Pain

2023
Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia.
    Archives of gynecology and obstetrics, 2023, Volume: 308, Issue:3

    Topics: Endometrial Hyperplasia; Endometrium; Estradiol; Female; Humans; Male; Nandrolone; Norethindrone; Norethindrone Acetate

2023
Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.
    Clinical therapeutics, 2023, Volume: 45, Issue:10

    Topics: Adenomyosis; Female; Humans; Levonorgestrel; Nandrolone; Pain

2023

Other Studies

233 other study(ies) available for nandrolone and dienogest

ArticleYear
Effect of fertility regulating agents on motility and zona-free hamster egg penetration by spermatozoa of bonnet monkey.
    Indian journal of experimental biology, 1992, Volume: 30, Issue:11

    Topics: Animals; Contraceptive Agents, Male; Cricetinae; Female; Fertility; Follicle Stimulating Hormone; Macaca radiata; Male; Nandrolone; Ovum; Sperm Motility; Sperm-Ovum Interactions; Testosterone; Zona Pellucida

1992
Effects of STS-557 and 20 Aet-1 on sperm functions and serum level of testosterone in bonnet monkey (Macaca radiata).
    Contraception, 1992, Volume: 45, Issue:5

    Topics: Animals; Contraceptive Agents, Male; Macaca radiata; Male; Nandrolone; Oligospermia; Sperm Count; Sperm Motility; Spermatozoa; Testosterone; Time Factors

1992
[Pharmacokinetics of contraceptive steroids with reference to long-term administration].
    Zentralblatt fur Gynakologie, 1991, Volume: 113, Issue:23

    Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Menstrual Cycle; Middle Aged; Nandrolone; Norgestrel; Reference Values

1991
Modulation of steroid production in goat ovarian cells: effect of progestins and antiprogestins.
    Endocrine research, 1990, Volume: 16, Issue:2

    Topics: Androstenedione; Androstenols; Animals; Corpus Luteum; Estradiol; Estrenes; Female; Follicle Stimulating Hormone; Gestrinone; Goats; Granulosa Cells; Nandrolone; Norethindrone; Progesterone; Progesterone Congeners; Progestins; Promegestone

1990
Effect of STS-557 (17 alpha-cyanomethyl 17 beta-hydroxy-estra-4, 9(10)-dien-3-one) on blood hormone levels, the testis, accessory sex organs and fertility of rats.
    International journal of andrology, 1990, Volume: 13, Issue:5

    Topics: Animals; Contraceptive Agents, Male; Female; Fertility; Follicle Stimulating Hormone; Genitalia, Male; Hormones; Luteinizing Hormone; Male; Nandrolone; Random Allocation; Rats; Sperm Count; Sperm Motility; Testis; Testosterone

1990
[Effect of a new gestagen--dienogest--and its combination with ethinyl estradiol on the activity of biotransformation reactions].
    Zentralblatt fur Gynakologie, 1990, Volume: 112, Issue:12

    Topics: Adult; Biotransformation; Caffeine; Contraceptives, Oral; Dipyrone; Estradiol; Ethinyl Estradiol; Female; Humans; Metabolic Clearance Rate; Nandrolone; Progesterone

1990
Contraceptive potentiality of STS-557--a feasibility study in male bonnet monkey (Macaca radiata).
    Contraception, 1990, Volume: 41, Issue:6

    Topics: Acid Phosphatase; Acrosin; Animals; Contraceptives, Oral; Dose-Response Relationship, Drug; Female; Fertility; Fructose; Glycerylphosphorylcholine; Hyaluronoglucosaminidase; Injections, Intramuscular; Male; Nandrolone; Progestins; Rabbits; Semen; Sperm Count; Sperm Motility; Sperm-Ovum Interactions; Spermatozoa; Testosterone

1990
Effect of antiandrogens on some key enzymes of glycolysis in epididymis and ventral prostate of rat.
    Indian journal of experimental biology, 1989, Volume: 27, Issue:4

    Topics: Androgen Antagonists; Animals; Body Weight; Cyproterone; Cyproterone Acetate; Enzymes; Epididymis; Estradiol; Flutamide; Glycolysis; Male; Nandrolone; Organ Size; Prostate; Rats

1989
Pharmacokinetics of the progestin dienogest (STS 557) in rabbits.
    Experimental and clinical endocrinology, 1989, Volume: 94, Issue:1-2

    Topics: Animals; Bile; Enterohepatic Circulation; Feces; Female; Intestine, Small; Nandrolone; Progesterone Congeners; Rabbits

1989
Studies on the biotransformation of the progestagen dienogest in the rabbit.
    Experimental and clinical endocrinology, 1989, Volume: 94, Issue:1-2

    Topics: Animals; Bile; Biotransformation; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Female; Nandrolone; Progesterone Congeners; Rabbits

1989
Lipid metabolism during treatment of endometriosis with the progestin dienogest.
    Acta obstetricia et gynecologica Scandinavica, 1989, Volume: 68, Issue:7

    Topics: Adolescent; Adult; Endometriosis; Female; Humans; Lipid Metabolism; Middle Aged; Nandrolone

1989
Carbohydrate metabolism during treatment of endometriosis with the progestin dienogest.
    Experimental and clinical endocrinology, 1989, Volume: 94, Issue:1-2

    Topics: Adolescent; Adult; Blood Glucose; Endometriosis; Female; Glucose Tolerance Test; Humans; Insulin; Nandrolone; Progesterone Congeners

1989
[The behavior of cytoplasmic progesterone receptors in the cycling endometrium and the effect of hormonal contraceptives].
    Zentralblatt fur Gynakologie, 1989, Volume: 111, Issue:12

    Topics: Adult; Contraceptives, Oral, Combined; Cytosol; Dose-Response Relationship, Drug; Endometrium; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Menstrual Cycle; Nandrolone; Norgestrel; Ovulation; Receptors, Progesterone

1989
[Behavior of parameters of liver metabolism in intermediate-term use of the gestagen dienogest in the treatment of endometriosis].
    Zentralblatt fur Gynakologie, 1989, Volume: 111, Issue:12

    Topics: Adolescent; Adult; Endometriosis; Female; Follow-Up Studies; Humans; Liver Function Tests; Middle Aged; Nandrolone; Progesterone Congeners; Uterine Neoplasms

1989
Interaction of antiprogestins with progesterone receptors in rat uterus.
    Journal of steroid biochemistry, 1989, Volume: 32, Issue:2

    Topics: Animals; Female; Nandrolone; Progestins; Rats; Receptors, Progesterone; Steroids; Uterus

1989
Synthetic antiprogestins stimulate human granulosa cell estradiol production in vitro.
    Experimental and clinical endocrinology, 1987, Volume: 89, Issue:2

    Topics: Adult; Androstenedione; Estradiol; Estrenes; Female; Follicle Stimulating Hormone; Granulosa Cells; Humans; In Vitro Techniques; Luteinizing Hormone; Middle Aged; Nandrolone; Progestins

1987
Effects of STS 557 on semen and sperm functions in bonnet monkey (Macaca radiata)--a preliminary report.
    Contraception, 1988, Volume: 37, Issue:6

    Topics: Acid Phosphatase; Animals; Contraceptive Agents, Male; Macaca radiata; Male; Nandrolone; Semen; Sperm Motility; Spermatozoa; Testosterone

1988
Evaluation of STS-557 as an oral contraceptive in male rat.
    Contraception, 1987, Volume: 36, Issue:2

    Topics: Animals; Contraceptive Agents, Male; Dose-Response Relationship, Drug; Epididymis; Genitalia, Male; Male; Nandrolone; Organ Size; Rats; Rats, Inbred Strains; Testis; Testosterone

1987
[Radioimmunologic determination of the progestagen dienogest in plasma and saliva].
    Die Pharmazie, 1986, Volume: 41, Issue:11

    Topics: Administration, Oral; Humans; Kinetics; Nandrolone; Progesterone Congeners; Radioimmunoassay; Saliva

1986
[Therapy of endometriosis with dienogest].
    Zentralblatt fur Gynakologie, 1987, Volume: 109, Issue:12

    Topics: Adolescent; Adult; Endometriosis; Female; Follow-Up Studies; Genital Neoplasms, Female; Humans; Middle Aged; Nandrolone; Progesterone Congeners

1987
[Bovine serum albumin conjugates of the new progestagen dienogest, synthesis and immunogenic properties].
    Die Pharmazie, 1986, Volume: 41, Issue:9

    Topics: Animals; Cattle; Immunization; Nandrolone; Progesterone Congeners; Radioimmunoassay; Serum Albumin, Bovine

1986
[Radioimmunoassay of the progestagen dienogest using various methods of sample preparation of plasma].
    Die Pharmazie, 1986, Volume: 41, Issue:10

    Topics: Chromatography, High Pressure Liquid; Humans; Nandrolone; Progesterone Congeners; Radioimmunoassay; Specimen Handling

1986
[Chromosome analysis of female baboons following treatment with STS 557 and levonorgestrel].
    Zentralblatt fur Gynakologie, 1985, Volume: 107, Issue:5

    Topics: Animals; Bone Marrow Cells; Chromosome Aberrations; Contraceptives, Oral, Combined; Contraceptives, Postcoital; Female; Humans; Levonorgestrel; Nandrolone; Norgestrel; Papio; Progesterone Congeners; Stereoisomerism

1985
Effects of antifertility estrogens and progestins on the endometrial surface of early pregnant rats. A scanning electron microscopic study.
    Experimental and clinical endocrinology, 1985, Volume: 85, Issue:2

    Topics: Animals; Contraceptives, Oral, Combined; Endometrium; Estriol; Estrogens; Female; Levonorgestrel; Mestranol; Microscopy, Electron, Scanning; Microvilli; Nandrolone; Norgestrel; Pregnancy; Pregnancy, Animal; Progestins; Rats; Rats, Inbred Strains

1985
Effects of the new progestagen STS 557 on the biosynthesis of steroids in tissue slices of the human ovary.
    Experimental and clinical endocrinology, 1985, Volume: 86, Issue:2

    Topics: Carbon Radioisotopes; Female; Gonadal Steroid Hormones; Humans; In Vitro Techniques; Nandrolone; Ovary; Pregnenolone; Progesterone Congeners

1985
Progestagenic and antigonadotrophic activities of STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Administration, Oral; Animals; Chlormadinone Acetate; Contraceptives, Oral, Combined; Female; Gonadotropins; Injections, Subcutaneous; Levonorgestrel; Nandrolone; Norethindrone; Norgestrel; Ovulation; Progesterone Congeners; Rabbits; Rats; Rats, Inbred Strains; Species Specificity

1983
Receptor binding of STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Chickens; Endometrium; Female; Humans; In Vitro Techniques; Kinetics; Nandrolone; Oviducts; Progesterone Congeners; Rabbits; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Cell Surface; Receptors, Progesterone

1983
Investigations on the mutagenic activity of STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Bone Marrow Cells; Chromosomes; DNA Repair; Female; Male; Mice; Mitochondria, Liver; Mutagenicity Tests; Mutagens; Nandrolone; Progesterone Congeners; Proteus mirabilis; Salmonella

1983
Interceptive activities of STS 557 in rabbits, mice and rats.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Amine Oxidase (Copper-Containing); Animals; Blastocyst; Contraceptive Agents, Female; Embryo Implantation; Fallopian Tubes; Female; Fertility; Male; Mice; Nandrolone; Pregnancy; Progesterone; Progesterone Congeners; Rabbits; Radioimmunoassay; Rats; Rats, Inbred Strains; Species Specificity

1983
Inhibition of male fertility by STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Contraceptives, Oral, Combined; Fertility; Fructose; Gonadotropins; Levonorgestrel; Male; Nandrolone; Norgestrel; Rabbits; Reproduction; Semen; Sialic Acids; Sperm Motility; Testosterone

1983
Pharmacological activities of the progestin STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anticonvulsants; Body Temperature; Contraceptives, Oral, Combined; Dogs; Drinking; Eating; Guinea Pigs; Hemodynamics; Lethal Dose 50; Levonorgestrel; Male; Mice; Motor Activity; Muscle, Smooth; Nandrolone; Norgestrel; Progesterone Congeners; Rats

1983
Data on acute toxicity of the progestin STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Body Temperature; Body Weight; Contraceptives, Oral, Combined; Drinking; Eating; Female; Lethal Dose 50; Levonorgestrel; Male; Mice; Motor Activity; Nandrolone; Norgestrel; Progesterone Congeners; Rabbits; Species Specificity

1983
Long term toxicological studies on the progestin STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Body Weight; Contraceptives, Oral, Combined; Dogs; Eating; Female; Glucose Tolerance Test; Hormones; Levonorgestrel; Male; Nandrolone; Norgestrel; Organ Size; Progesterone Congeners; Rats; Time Factors

1983
STS 557 as an interceptive in baboons.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Levonorgestrel; Menstruation; Nandrolone; Norgestrel; Papio; Progesterone; Progesterone Congeners

1983
Influence of STS 557 on the mitotic activity in the endometrium of ovariectomized mice and comparison with the effects of progesterone and levonorgestrel.
    Experimental and clinical endocrinology, 1984, Volume: 83, Issue:3

    Topics: Animals; Castration; Contraceptives, Oral; Contraceptives, Oral, Combined; Endometrium; Female; Levonorgestrel; Mice; Mitosis; Nandrolone; Norgestrel; Progesterone

1984
The effect of a single midcycle administration of 0.5 or 2.0 mg dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one) on pituitary and ovarian function--investigation for the use as a postcoital contraceptive.
    Experimental and clinical endocrinology, 1984, Volume: 84, Issue:3

    Topics: Adult; Body Temperature; Contraceptives, Postcoital; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Nandrolone; Ovary; Pituitary Gland; Progesterone

1984
On the effect of the new progestagen dienogest (STS 557) on the proliferative responses of rabbit blood lymphocytes to mitogens.
    Die Pharmazie, 1984, Volume: 39, Issue:8

    Topics: Animals; Concanavalin A; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Mitogens; Nandrolone; Phytohemagglutinins; Progesterone Congeners; Rabbits

1984
Fertilizing ability of spermatozoa of rats treated with STS 557.
    Archives of andrology, 1983, Volume: 11, Issue:2

    Topics: Animals; Contraceptives, Oral; Female; Fertility; Fructose; Male; Nandrolone; Rats; Semen; Sperm Motility; Spermatozoa

1983
Urinary metabolites of the new progestagen STS 557 (17 alpha-cyanomethyl-17-hydroxy-4,9-estradien-3-one) in the dog and rat.
    Steroids, 1983, Volume: 41, Issue:1

    Topics: Administration, Oral; Animals; Chromatography, Thin Layer; Dogs; Female; Kinetics; Male; Mass Spectrometry; Nandrolone; Progesterone Congeners; Rats; Rats, Inbred Strains; Species Specificity; Spectrophotometry, Ultraviolet

1983
Preclinical data on STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Nandrolone; Progesterone Congeners

1983
Preclinical data on STS 557. Introduction.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Chemical Phenomena; Chemistry; Nandrolone; Progesterone Congeners

1983
The synthetic approach to STS 557 - structure activity relationships in 17 alpha-CH2X-substituted 19-nortestosterone derivatives.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Female; Nandrolone; Progesterone Congeners; Rabbits; Structure-Activity Relationship

1983
Studies on pharmacokinetics of STS 557 in animal species and man.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Blood Proteins; Dogs; Female; Humans; Kinetics; Male; Nandrolone; Papio; Progesterone Congeners; Protein Binding; Rats; Species Specificity

1983
Studies on biotransformation of STS 557.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Bacteria; Biotransformation; Clostridium; Female; In Vitro Techniques; Microsomes, Liver; Mycobacterium; Nandrolone; Progesterone Congeners; Rats; Rhodotorula

1983
Prenatal toxic effects of STS 557. I. Investigations in mice.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Animals; Body Weight; Embryo, Mammalian; Female; Fetus; Mice; Nandrolone; Pregnancy; Progesterone Congeners; Teratogens

1983
Prenatal toxic effects of STS 557. II. Investigation in rabbits--preliminary results.
    Experimental and clinical endocrinology, 1983, Volume: 81, Issue:2

    Topics: Abnormalities, Drug-Induced; Animals; Corpus Luteum; Estrus; Female; Fetal Resorption; Nandrolone; Pregnancy; Progesterone Congeners; Rabbits

1983
Influence of a 9-double bond on stereospecific microbial 4,5-reductions.
    Journal of steroid biochemistry, 1983, Volume: 18, Issue:1

    Topics: Clostridium; Mitosporic Fungi; Nandrolone; Rhodotorula; Species Specificity; Stereoisomerism; Structure-Activity Relationship

1983
Effects of levonorgestrel and STS 557 on testis in rodents.
    Endokrinologie, 1980, Volume: 76, Issue:1

    Topics: Animals; Castration; DNA; Female; Fertility; Levonorgestrel; Libido; Luteinizing Hormone; Male; Nandrolone; Norgestrel; Organ Size; Pregnancy; Rats; Sexual Maturation; Testis

1980
[Chromosomal analysis of baboons and their mothers, following application to mothers of potentially post-ovulation fertility-inhibiting steroids (author's transl)].
    Zentralblatt fur Gynakologie, 1981, Volume: 103, Issue:20

    Topics: Animals; Bone Marrow Cells; Chromosome Aberrations; Chromosome Mapping; Contraceptives, Postcoital; Contraceptives, Postcoital, Synthetic; Female; Levonorgestrel; Lymphocytes; Nandrolone; Norgestrel; Papio; Pregnancy

1981
Toxicity of the progestagen STS 557 compared to levonorgestrel in beagles after oral administration for 6 months.
    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement, 1982, Volume: 5

    Topics: 11-Hydroxycorticosteroids; Administration, Oral; Animals; Dogs; Female; Levonorgestrel; Male; Nandrolone; Norgestrel; Progesterone Congeners; Time Factors

1982
Further report on the interceptive STS 557 in baboons.
    Endokrinologie, 1982, Volume: 79, Issue:3

    Topics: Administration, Oral; Animals; Contraceptives, Oral, Combined; Female; Levonorgestrel; Nandrolone; Norgestrel; Papio; Pregnancy; Progesterone

1982
[Changes in vaginal cytograms of female beagle dogs during toxicologic long-term examinations of gestagens].
    Zeitschrift fur Versuchstierkunde, 1982, Volume: 24, Issue:3

    Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dogs; Estrus; Female; Levonorgestrel; Long-Term Care; Menstruation; Nandrolone; Norgestrel; Pregnancy; Vaginal Smears

1982
Further report on the endocrinological profile of 17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9(10)-diene-3-one (STS 557) in rodents.
    Endokrinologie, 1982, Volume: 79, Issue:2

    Topics: Animals; Contraceptives, Oral; Female; Mice; Nandrolone; Organ Size; Ovary; Pregnancy; Pregnancy, Animal; Progesterone Congeners; Rats; Rats, Inbred Strains; Rodentia; Uterus; Vagina

1982
Microbial transformation of 17 alpha-cyanomethyl-17-hydroxy-4,9-estradien-3-one (STS 557) and 17 alpha-cyanomethyl-19-nortestosterone by Mycobacterium smegmatis.
    Steroids, 1982, Volume: 39, Issue:4

    Topics: Biotransformation; Chemical Phenomena; Chemistry; Hydrogenation; Mycobacterium; Nandrolone

1982
Evaluation of STS-557 as a postcoital contraceptive in the baboon.
    Contraception, 1981, Volume: 23, Issue:3

    Topics: Animals; Contraceptives, Oral; Contraceptives, Postcoital; Estradiol; Female; Nandrolone; Papio; Progesterone; Progesterone Congeners

1981
STS 557, a new orally active progestin with antiprogestational and contragestational properties in rabbits.
    Contraception, 1980, Volume: 21, Issue:1

    Topics: Animals; Contraceptives, Oral; Dose-Response Relationship, Drug; Embryo Implantation; Endometrium; Estrenes; Female; Fertilization; Nandrolone; Norgestrel; Ovary; Ovum Transport; Pregnancy; Progesterone Congeners; Rabbits; Receptors, Progesterone

1980
[The endocrinologic profile of metabolites of the progestin dienogest].
    Die Pharmazie, 1993, Volume: 48, Issue:7

    Topics: Androgen Antagonists; Animals; Endometrium; Estradiol Congeners; Female; Fertility; In Vitro Techniques; Male; Mice; Nandrolone; Pregnancy; Progestins; Rabbits; Rats; Rats, Wistar; Receptors, Progesterone

1993
Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Cancer, 1997, Jan-01, Volume: 79, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Hormone Antagonists; Humans; Mice; Mice, SCID; Nandrolone; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured

1997
Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid.
    Drugs under experimental and clinical research, 1997, Volume: 23, Issue:2

    Topics: Animals; Carbonic Anhydrases; Castration; Cell Division; Contraceptives, Oral; Endometriosis; Endometrium; Enzyme Induction; Female; Hormone Antagonists; Humans; Male; Nandrolone; Ovulation; Rabbits; Rats; Receptors, Progesterone; Receptors, Steroid; Sex Hormone-Binding Globulin

1997
Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats.
    European journal of endocrinology, 1998, Volume: 138, Issue:2

    Topics: Animals; Buserelin; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytotoxicity, Immunologic; Danazol; Disease Models, Animal; Endometriosis; Enzyme Inhibitors; Estradiol; Female; Immunity, Cellular; Interleukin-1; Killer Cells, Natural; Macrophages, Peritoneal; Nandrolone; Progesterone; Progesterone Congeners; Protein Kinase C; Rats; Rats, Sprague-Dawley

1998
Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins.
    Maturitas, 1997, Dec-15, Volume: 28, Issue:2

    Topics: Animals; Aorta, Thoracic; Chlormadinone Acetate; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; Hormone Antagonists; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nandrolone; Norethindrone; Phenylephrine; Progesterone; Progesterone Congeners; Rats; Rats, Wistar; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Verapamil

1997
Effects of dienogest (a synthetic steroid) on coagulation, fibrinolysis, and platelet aggregation in female monkeys.
    Toxicology letters, 1998, Sep-01, Volume: 98, Issue:1-2

    Topics: Animals; Blood Coagulation; Blood Platelets; Cholesterol; Danazol; Female; Fibrinolysis; Hormone Antagonists; Macaca fascicularis; Macaca mulatta; Medroxyprogesterone Acetate; Nandrolone; Phospholipids; Platelet Aggregation

1998
Effect of dienogest on bleeding time, coagulation, fibrinolysis, and platelet aggregation in female rats.
    Toxicology letters, 1999, Jan-11, Volume: 104, Issue:1-2

    Topics: Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Cholesterol; Contraceptives, Oral; Danazol; Female; Fibrinolysis; Lipids; Medroxyprogesterone Acetate; Nandrolone; Phospholipids; Platelet Aggregation; Rats

1999
Effect of 17 alpha-cyanomethyl-17 beta-hydroxy-estra-4, 9-dien-3-one on reproductive organs of the male laboratory mouse.
    Indian journal of experimental biology, 1998, Volume: 36, Issue:11

    Topics: Animals; Genitalia, Male; Male; Mice; N-Acetylneuraminic Acid; Nandrolone; Organ Size; Progesterone Congeners; Spermatozoa; Testis

1998
Endometriosis: a clinically malignant disease.
    European journal of obstetrics, gynecology, and reproductive biology, 1999, Volume: 82, Issue:2

    Topics: Adult; Colonic Diseases; Endometriosis; Female; Hormone Antagonists; Humans; Intestinal Obstruction; Nandrolone; Rectal Diseases; Uremia; Ureteral Obstruction

1999
Nitrile hydratase from Rhodococcus erythropolis: metabolization of steroidal compounds with a nitrile group.
    Steroids, 1999, Volume: 64, Issue:8

    Topics: Animals; Biotransformation; Drug Evaluation, Preclinical; Estradiol; Fermentation; Hydro-Lyases; Hydrolysis; Nandrolone; Progesterone; Pyridines; Rabbits; Receptors, Estrogen; Rhodococcus; Structure-Activity Relationship

1999
The efficacy and tolerability of Valette: a postmarketing surveillance study.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 1999, Volume: 4, Issue:3

    Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Germany; Hormone Antagonists; Humans; Liver; Menstruation; Nandrolone; Pregnancy; Product Surveillance, Postmarketing; Pulmonary Embolism; Thrombosis

1999
Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis.
    European journal of pharmacology, 1999, Dec-10, Volume: 386, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Hormonal; Cell Division; Chorion; Depression, Chemical; Embryo, Mammalian; Endothelium, Vascular; Female; Mice; Mice, Inbred ICR; Microcirculation; Nandrolone; Neovascularization, Pathologic; Neovascularization, Physiologic; Plasminogen Activators; Regional Blood Flow; Tumor Cells, Cultured

1999
Influence of sexual steroids on cell functions of PMNL in the gingival sulcus.
    Die Pharmazie, 2000, Volume: 55, Issue:9

    Topics: Candida albicans; Cell Count; Estradiol; Gingiva; Gonadal Steroid Hormones; Hormone Antagonists; Humans; Nandrolone; Neutrophils; Periodontitis; Phagocytosis

2000
Growth-stimulating effect of dienogest, a synthetic steroid, on rodent, canine, and primate mammary glands.
    Toxicology, 2000, Oct-26, Volume: 151, Issue:1-3

    Topics: Animals; Cells, Cultured; Dogs; Epithelium; Female; Hormone Antagonists; Human Growth Hormone; Humans; Immunohistochemistry; Macaca mulatta; Mammary Glands, Animal; Medroxyprogesterone Acetate; Nandrolone; Progesterone Congeners; Rats; Stimulation, Chemical

2000
Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2000, Volume: 14, Issue:4

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Adolescent; Adult; Contraceptives, Oral; Dose-Response Relationship, Drug; Female; Humans; Hyperandrogenism; Nandrolone; Norgestrel; Progestins; Receptors, Androgen; Skin

2000
The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro.
    Molecular human reproduction, 2001, Volume: 7, Issue:4

    Topics: Cell Division; Cells, Cultured; Contraceptives, Oral; Endometrium; Estradiol; Female; Hormone Antagonists; Humans; Mifepristone; Molecular Structure; Nandrolone; Progesterone; Prolactin; Steroids

2001
Non-protein bound dienogest in serum and salivary dienogest in women taking the oral contraceptives Certostat and Valette.
    Die Pharmazie, 2001, Volume: 56, Issue:4

    Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral; Female; Humans; Levonorgestrel; Nandrolone; Protein Binding; Radioimmunoassay; Saliva; Ultrafiltration

2001
[Endometriosis of the lungs: analysis of diagnosis and therapy].
    Ginekologia polska, 2001, Volume: 72, Issue:5

    Topics: Adolescent; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Lung Diseases; Nandrolone; Thoracotomy

2001
Estimation of hormone replacement therapy influence on serum galanin level in postmenopausal women.
    Climacteric : the journal of the International Menopause Society, 2001, Volume: 4, Issue:3

    Topics: Adult; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Galanin; Humans; Levonorgestrel; Middle Aged; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause

2001
The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2001, Volume: 33, Issue:12

    Topics: Adult; Contraceptives, Oral; Estradiol; Estrogen Replacement Therapy; Estrogens, Catechol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Middle Aged; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause

2001
Treatment of menstruation-associated recurrence of hereditary pancreatitis with pharmacologic ovarian suppression.
    The American journal of medicine, 2002, Aug-01, Volume: 113, Issue:2

    Topics: Adolescent; Contraceptives, Oral, Hormonal; Estradiol; Female; Follow-Up Studies; Genetic Diseases, Inborn; Humans; Menstrual Cycle; Nandrolone; Ovary; Pancreatitis; Recurrence; Risk Assessment; Treatment Outcome

2002
Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins.
    Maturitas, 2002, Aug-30, Volume: 42, Issue:4

    Topics: Arteriosclerosis; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Levonorgestrel; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Receptors, Androgen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Vascular Cell Adhesion Molecule-1

2002
Impact of hormone replacement therapy on endogenous estradiol metabolism in postmenopausal women.
    Maturitas, 2002, Oct-25, Volume: 43, Issue:2

    Topics: Estradiol; Female; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause

2002
Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in the Czech Republic.
    Methods and findings in experimental and clinical pharmacology, 2002, Volume: 24, Issue:10

    Topics: Adolescent; Adult; Breast Diseases; Contraceptives, Oral, Combined; Cytochrome P-450 CYP1A1; Depression; Drug Administration Schedule; Female; Gastrointestinal Diseases; Headache; Humans; Nandrolone; Prospective Studies; Skin Diseases; Steroid Hydroxylases; Treatment Failure; Treatment Outcome

2002
[Hormone use in migraine].
    Deutsche medizinische Wochenschrift (1946), 2003, Aug-15, Volume: 128, Issue:33

    Topics: Adult; Chronic Disease; Contraceptives, Oral; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Migraine Disorders; Nandrolone; Ovulation Inhibition; Recurrence; Time Factors

2003
Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives.
    Contraception, 2004, Volume: 69, Issue:1

    Topics: Adolescent; Adult; Attitude of Health Personnel; Contraceptives, Oral; Female; Germany; Gynecology; Health Knowledge, Attitudes, Practice; Humans; Menstrual Cycle; Menstruation; Middle Aged; Nandrolone; Physicians; Pregnancy; Surveys and Questionnaires; Women

2004
Endogenous estradiol metabolism during treatment with oral contraceptives.
    International journal of clinical pharmacology and therapeutics, 2004, Volume: 42, Issue:3

    Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Levonorgestrel; Nandrolone; Norethindrone; Premenopause; Randomized Controlled Trials as Topic

2004
DNA fragmentation, DNA repair and apoptosis induced in primary rat hepatocytes by dienogest, dydrogesterone and 1,4,6-androstatriene-17beta-ol-3-one acetate.
    Mutation research, 2004, Nov-14, Volume: 564, Issue:1

    Topics: Androstatrienes; Animals; Apoptosis; Aromatase Inhibitors; Cells, Cultured; DNA; DNA Fragmentation; DNA Repair; Dydrogesterone; Female; Hepatocytes; Hormone Antagonists; Male; Molecular Structure; Mutagenicity Tests; Nandrolone; Rats; Rats, Sprague-Dawley

2004
Progestins and estrogens and Alzheimer's disease.
    The Journal of steroid biochemistry and molecular biology, 2005, Volume: 93, Issue:2-5

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cell Adhesion; Cells, Cultured; Cognition; Estradiol; Estradiol Congeners; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Progesterone Congeners; Rats

2005
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men.
    Journal of endocrinological investigation, 2005, Volume: 28, Issue:3

    Topics: Adult; Androgens; Anthropometry; Blood Pressure; Body Weight; Contraceptive Agents, Male; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Estradiol; Ghrelin; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Nandrolone; Peptide Hormones; Testosterone

2005
High-dose pilot study with the novel progestogen dienogestin patients with endometriosis.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:1

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pilot Projects; Statistics, Nonparametric; Treatment Outcome

2006
Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells.
    Fertility and sterility, 2008, Volume: 89, Issue:5 Suppl

    Topics: Adult; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Cells, Cultured; Contraceptives, Oral; DNA; Drug Evaluation, Preclinical; Endometriosis; Female; G1 Phase; Humans; Nandrolone; Ovarian Diseases; Resting Phase, Cell Cycle; Stromal Cells

2008
Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives.
    European journal of obstetrics, gynecology, and reproductive biology, 2008, Volume: 137, Issue:1

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Androgen Antagonists; Androstenes; Case-Control Studies; Chlormadinone Acetate; Clobetasol; Contraceptives, Oral; Cyproterone Acetate; Female; Glucocorticoids; Humans; Imiquimod; Incidence; Nandrolone; Premenopause; Progesterone; Retrospective Studies; Risk Factors; Treatment Outcome; Vulvar Lichen Sclerosus

2008
Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
    Steroids, 2008, Volume: 73, Issue:2

    Topics: Androgen Receptor Antagonists; Animals; Endometrium; Female; Humans; Nandrolone; Rabbits; Receptors, Androgen; Receptors, Progesterone; Receptors, Steroid

2008
Dienogest, a selective progestin, reduces plasma estradiol level through induction of apoptosis of granulosa cells in the ovarian dominant follicle without follicle-stimulating hormone suppression in monkeys.
    Journal of endocrinological investigation, 2008, Volume: 31, Issue:7

    Topics: Animals; Apoptosis; Estradiol; Female; Follicle Stimulating Hormone; Follicular Atresia; Granulosa Cells; Hormone Antagonists; Humans; Macaca fascicularis; Menstrual Cycle; Nandrolone; Ovarian Follicle; Progesterone; Progestins

2008
Trials for development of once-a-month injectable, hormonal male contraceptive using dienogest plus testosterone undecanoate: dose standardization, efficacy and reversibility studies in rats.
    Contraception, 2009, Volume: 79, Issue:6

    Topics: alpha-Glucosidases; Animals; Apoptosis; Blood Chemical Analysis; Contraception; Contraceptive Agents, Male; Epididymis; Female; Histocytochemistry; In Situ Nick-End Labeling; Injections, Intravenous; Litter Size; Male; Nandrolone; Pregnancy; Rats; Rats, Wistar; Sperm Count; Spermatogenesis; Testis; Testosterone

2009
Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression.
    Molecular human reproduction, 2009, Volume: 15, Issue:10

    Topics: Blotting, Western; Cell Cycle; Cell Line; Cyclin D1; Cyclin E; Endometrium; Female; Gene Expression Regulation; Hormone Antagonists; Humans; Immunohistochemistry; Nandrolone; Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction

2009
Why use of dienogest for the first contraceptive pill with estradiol?
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010, Volume: 26, Issue:2

    Topics: Adolescent; Adult; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Humans; Middle Aged; Nandrolone; Young Adult

2010
After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2010, Volume: 15, Issue:1

    Topics: Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; History, 20th Century; Humans; Nandrolone; Progestins

2010
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
    The journal of family planning and reproductive health care, 2010, Volume: 36, Issue:3

    Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Logistic Models; Middle Aged; Mineralocorticoid Receptor Antagonists; Nandrolone; Risk Factors; Venous Thromboembolism; Young Adult

2010
Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model.
    Human reproduction (Oxford, England), 2010, Volume: 25, Issue:11

    Topics: Animals; Endometriosis; Endometrium; Female; Hemodynamics; Nandrolone; Neovascularization, Physiologic; Rats; Rats, Wistar

2010
Natazia--a new oral contraceptive.
    The Medical letter on drugs and therapeutics, 2010, Sep-06, Volume: 52, Issue:1346

    Topics: Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Approval; Estradiol; Female; Humans; Nandrolone; United States; United States Food and Drug Administration

2010
Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system.
    Steroids, 2011, Volume: 76, Issue:1-2

    Topics: Aromatase; Cell Culture Techniques; Cells, Cultured; Dinoprostone; Endometrium; Epithelial Cells; Female; Humans; Nandrolone; Reverse Transcriptase Polymerase Chain Reaction; Spheroids, Cellular

2011
[Evaluation of obesity in a 22-year-old female patient].
    Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:41

    Topics: Blood Sedimentation; Contraceptives, Oral, Combined; Cushing Syndrome; Dexamethasone; Diagnosis, Differential; Ethinyl Estradiol; Female; Giant Cell Arteritis; Headache; Humans; Hydrocortisone; Nandrolone; Obesity, Morbid; Predictive Value of Tests; Young Adult

2010
Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Archives of gynecology and obstetrics, 2011, Volume: 284, Issue:3

    Topics: Adult; Antineoplastic Agents, Hormonal; Case-Control Studies; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Leiomyoma; Leuprolide; Middle Aged; Nandrolone; Premenopause; Retrospective Studies; Tumor Burden; Uterine Neoplasms

2011
Dienogest, a new conservative strategy for extragenital endometriosis: a pilot study.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2011, Volume: 27, Issue:9

    Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Pilot Projects; Rectal Diseases; Retrospective Studies; Sigmoid Diseases; Urinary Bladder Diseases

2011
Oral contraceptives and heavy periods.
    Obstetrics and gynecology, 2011, Volume: 117, Issue:4

    Topics: Contraceptives, Oral; Estradiol; Female; Humans; Menorrhagia; Nandrolone

2011
Novel [corrected] medical management of primary bladder endometriosis with dienogest: a case report.
    Clinical and experimental obstetrics & gynecology, 2011, Volume: 38, Issue:2

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pregnancy; Urinary Bladder; Urinary Bladder Diseases

2011
Estradiol valerate and dienogest: a novel four-phasic oral contraceptive pill effective for pregnancy prevention and treatment of heavy menstrual bleeding.
    Women's health (London, England), 2011, Volume: 7, Issue:5

    Topics: Contraceptive Agents; Contraceptives, Oral; Drug Combinations; Drug Evaluation; Estradiol; Female; Humans; Menorrhagia; Nandrolone; Randomized Controlled Trials as Topic

2011
Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration.
    Gynecologic and obstetric investigation, 2011, Volume: 72, Issue:3

    Topics: Animals; Danazol; Disease Models, Animal; Endometriosis; Endometrium; Female; Hormone Antagonists; Nandrolone; Ovary; Rats; Rats, Sprague-Dawley; RNA, Messenger; Treatment Outcome; Uterus; Vascular Endothelial Growth Factor A

2011
Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells.
    Fertility and sterility, 2011, Volume: 96, Issue:6

    Topics: Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Endometrium; Epithelial Cells; Female; Gene Expression Regulation; Gene Knockdown Techniques; HMGB1 Protein; Hormone Antagonists; Humans; Interleukin-8; Lipopolysaccharides; Nandrolone; RNA, Small Interfering; Toll-Like Receptor 4

2011
Extended intervention time and evaluation of sperm suppression by dienogest plus testosterone undecanoate in male rat.
    Contraception, 2012, Volume: 85, Issue:1

    Topics: Androgens; Animals; Apoptosis; Contraceptive Agents, Male; Hormones; Male; Nandrolone; Rats; Rats, Wistar; Spermatogenesis; Testosterone

2012
Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture.
    Fertility and sterility, 2012, Volume: 97, Issue:2

    Topics: Adult; Aromatase; Aromatase Inhibitors; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; DNA; Dose-Response Relationship, Drug; Down-Regulation; Endometriosis; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Enzymologic; Humans; Immunohistochemistry; Nandrolone; NF-kappa B; Ovarian Diseases; Ovary; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spheroids, Cellular; Stromal Cells; Young Adult

2012
Dienogest. Endometriosis: still no progress.
    Prescrire international, 2011, Volume: 20, Issue:122

    Topics: Endometriosis; Female; Humans; Nandrolone

2011
Complete sperm suppression induced by dienogest plus testosterone undecanoate is associated with down-regulation in the expression of upstream steroidogenic enzyme genes in rat testis.
    Contraception, 2012, Volume: 86, Issue:2

    Topics: 3-Hydroxysteroid Dehydrogenases; Androgens; Animals; Cholesterol Side-Chain Cleavage Enzyme; Contraceptive Agents, Male; Down-Regulation; Drug Synergism; Injections, Intramuscular; Male; Nandrolone; Organ Size; Phosphoproteins; Rats; Rats, Wistar; RNA, Messenger; Seminiferous Tubules; Spermatogenesis; Spermatogonia; Steroid 17-alpha-Hydroxylase; Testis; Testosterone

2012
Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest.
    The journal of obstetrics and gynaecology research, 2012, Volume: 38, Issue:4

    Topics: Adult; Endometriosis; Female; Hemoglobins; Humans; Middle Aged; Nandrolone; Proportional Hazards Models; Retrospective Studies; Risk Factors; Uterine Hemorrhage

2012
Effects of progestins on local estradiol biosynthesis and action in the Z-12 endometriotic epithelial cell line.
    The Journal of steroid biochemistry and molecular biology, 2012, Volume: 132, Issue:3-5

    Topics: Aromatase; Cell Line; Cell Membrane; Cell Nucleus; Dydrogesterone; Endometriosis; Epithelial Cells; Estradiol; Estradiol Dehydrogenases; Estrogen Receptor alpha; Female; Gene Expression Regulation, Enzymologic; Humans; Medroxyprogesterone Acetate; Nandrolone; Progestins; Receptors, Estrogen; Receptors, G-Protein-Coupled

2012
Effective salvage of acute massive uterine bleeding using intrauterine balloon tamponade in a uterine adenomyosis patient on dienogest.
    The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:3

    Topics: Adenomyosis; Adult; Antineoplastic Agents, Hormonal; Female; Humans; Nandrolone; Uterine Balloon Tamponade; Uterine Hemorrhage

2013
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:2

    Topics: Breast Neoplasms; Cell Proliferation; Clone Cells; Contraceptive Agents, Female; Drug Interactions; Estradiol; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Norethindrone; Osmolar Concentration; Progesterone; Progestins; Receptors, Progesterone; Recombinant Proteins

2013
Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
    Chemico-biological interactions, 2013, Feb-25, Volume: 202, Issue:1-3

    Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aldo-Keto Reductase Family 1 Member C3; Cells, Cultured; Down-Regulation; Dydrogesterone; Endometriosis; Endometrium; Epithelial Cells; Estradiol Dehydrogenases; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Hydroxysteroid Dehydrogenases; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Progesterone; Progestins; Receptors, Progesterone; RNA, Messenger

2013
Complete sperm suppression in rats with dienogest plus testosterone undecanoate is facilitated through apoptosis in testicular cells.
    Reproductive sciences (Thousand Oaks, Calif.), 2013, Volume: 20, Issue:7

    Topics: Animals; Apoptosis; Drug Therapy, Combination; Male; Nandrolone; Rats; Rats, Wistar; Spermatozoa; Testis; Testosterone

2013
Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women.
    Contraception, 2013, Volume: 87, Issue:6

    Topics: Administration, Oral; Adult; Contraceptives, Oral; Female; Half-Life; Humans; Metabolic Clearance Rate; Nandrolone; Progestins; Reproducibility of Results; Republic of Korea; Tablets; Young Adult

2013
Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
    Contraception, 2013, Volume: 88, Issue:3

    Topics: Adult; Analgesics; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Dysmenorrhea; Estradiol; Female; Humans; Italy; Menstruation; Migraine Disorders; Nandrolone; Pilot Projects; Prospective Studies; Treatment Outcome

2013
Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism.
    Contraception, 2013, Volume: 88, Issue:3

    Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Italy; Nandrolone; Overweight; Polycystic Ovary Syndrome; Young Adult

2013
Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: an observational, preliminary study.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2013, Volume: 18, Issue:5

    Topics: Absorptiometry, Photon; Adult; Amino Acids; Bone and Bones; Bone Density; Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estradiol; Female; Humans; Lumbar Vertebrae; Nandrolone; Osteocalcin; Time Factors; Young Adult

2013
[Endometriosis, an underestimated disease: reducing pelvic pain effectively and lastingly].
    Revue medicale suisse, 2013, Jun-26, Volume: 9, Issue:392

    Topics: Analgesics; Contraceptives, Oral; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Treatment Outcome

2013
Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:12

    Topics: Acne Vulgaris; Adolescent; Androgens; Contraceptives, Oral, Hormonal; Estradiol; Female; Humans; Longitudinal Studies; Nandrolone; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Young Adult

2013
Effect of a dienogest for an experimental three-dimensional endometrial culture model for endometriosis.
    Medical molecular morphology, 2014, Volume: 47, Issue:4

    Topics: Adult; Apoptosis; Cell Culture Techniques; Cell Proliferation; Cells, Cultured; Endometriosis; Endometrium; Epithelial Cells; Female; Hormone Antagonists; Humans; Middle Aged; Models, Biological; Nandrolone; Tissue Culture Techniques

2014
Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β.
    Fertility and sterility, 2014, Volume: 101, Issue:2

    Topics: Animals; Cell Line, Transformed; Female; Hormone Antagonists; Humans; Inflammation Mediators; Interleukin-1beta; Nandrolone; Nerve Growth Factor; PC12 Cells; Prospective Studies; Rats; Tumor Necrosis Factor-alpha; Up-Regulation

2014
Surgery versus pharmacological treatment for endometriosis.
    Women's health (London, England), 2014, Volume: 10, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Combined; Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Infertility, Female; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Nandrolone; Pelvic Pain; Progestins

2014
Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis.
    European journal of obstetrics, gynecology, and reproductive biology, 2014, Volume: 177

    Topics: Adult; Ascitic Fluid; Cells, Cultured; Endometriosis; Female; HLA-DR Antigens; Hormone Antagonists; Humans; Macrophages; Nandrolone; Peritoneal Diseases; Tumor Necrosis Factor-alpha

2014
Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:9

    Topics: Antineoplastic Agents, Hormonal; Apoptosis; Aromatase; Case-Control Studies; Cell Proliferation; Endometriosis; Female; Humans; In Situ Nick-End Labeling; Ki-67 Antigen; Nandrolone; Neovascularization, Pathologic; von Willebrand Factor

2014
Prediction of the therapeutic effect of dienogest in ovarian endometrial cysts using the apparent diffusion coefficient.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:8

    Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers, Pharmacological; Diffusion; Diffusion Magnetic Resonance Imaging; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Cysts; Predictive Value of Tests; Prognosis; Retrospective Studies

2014
A simple, rapid and sensitive liquid chromatography-tandem mass spectrometry method for the determination of dienogest in human plasma and its pharmacokinetic applications under fasting.
    Biomedical chromatography : BMC, 2015, Volume: 29, Issue:2

    Topics: Chromatography, Liquid; Humans; Nandrolone; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry

2015
Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:10

    Topics: Adenomyosis; Adult; Female; Humans; Metrorrhagia; Middle Aged; Nandrolone; Pilot Projects; Progesterone Congeners; Treatment Outcome

2014
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:9

    Topics: Adult; Body Composition; Chlormadinone Acetate; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Metabolism; Nandrolone; Prospective Studies

2014
Progesterone and synthetic progestin, dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells.
    European journal of obstetrics, gynecology, and reproductive biology, 2014, Volume: 179

    Topics: Adenomyosis; Adult; Apoptosis; Cell Proliferation; Cells, Cultured; Endometrium; Estradiol; Female; Humans; Middle Aged; Nandrolone; Progesterone; Stromal Cells

2014
Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:11

    Topics: Adult; Drug Administration Schedule; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Treatment Outcome; Uterine Hemorrhage; Young Adult

2014
Endometriosis associated with relapsing ascites and pleural effusions.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2015, Volume: 35, Issue:4

    Topics: Adult; Ascites; Endometriosis; Female; Hormone Antagonists; Humans; Leuprolide; Nandrolone; Ovarian Cysts; Paracentesis; Peritoneal Cavity; Pleura; Pleural Effusion; Treatment Outcome

2015
Urinary incontinence and bladder endometriosis: conservative management.
    International urogynecology journal, 2015, Volume: 26, Issue:1

    Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Nandrolone; Urinary Bladder Diseases; Urinary Incontinence

2015
Decorin induced by progesterone plays a crucial role in suppressing endometriosis.
    The Journal of endocrinology, 2014, Volume: 223, Issue:2

    Topics: Adult; Cell Cycle; Cells, Cultured; Cross-Sectional Studies; Decorin; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Progesterone; Retrospective Studies; Transcriptional Activation; Young Adult

2014
Effects of estradiol valerate and dienogest on quality of life and sexual function according to age.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:12

    Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Female; Humans; Libido; Middle Aged; Nandrolone; Personal Satisfaction; Quality of Life; Sexual Behavior; Surveys and Questionnaires

2014
Protective effect of dienogest on chemotherapy-induced reduced fertility in female rats.
    Steroids, 2015, Volume: 93

    Topics: Animals; Antineoplastic Agents, Alkylating; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Fertility Agents; Gonadotropin-Releasing Hormone; Infertility, Female; Male; Nandrolone; Ovarian Follicle; Ovary; Pregnancy; Rats, Sprague-Dawley

2015
Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells.
    The Journal of steroid biochemistry and molecular biology, 2015, Volume: 147

    Topics: Aromatase; Cell Line; Cytokines; Down-Regulation; Endometriosis; Female; Humans; Intramolecular Oxidoreductases; Nandrolone; Nerve Growth Factor; Progesterone Congeners; Prostaglandin-E Synthases; Receptors, Progesterone; RNA, Messenger; Vascular Endothelial Growth Factor A

2015
Dienogest reduces HSD17β1 expression and activity in endometriosis.
    The Journal of endocrinology, 2015, Volume: 225, Issue:2

    Topics: Adult; Aromatase; Cells, Cultured; Endometriosis; Endometrium; Estradiol Dehydrogenases; Female; Gene Expression Regulation, Enzymologic; Humans; Nandrolone; Young Adult

2015
Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2015, Volume: 31, Issue:5

    Topics: Adult; Cohort Studies; Dysuria; Endometriosis; Female; Hematuria; Hormone Antagonists; Humans; Nandrolone; Pilot Projects; Quality of Life; Treatment Outcome; Ultrasonography; Urinary Bladder Diseases

2015
Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts.
    The journal of obstetrics and gynaecology research, 2015, Volume: 41, Issue:8

    Topics: Adult; Anti-Mullerian Hormone; Endometriosis; Female; Humans; Laparoscopy; Leuprolide; Nandrolone; Ovarian Cysts; Ovary; Visual Analog Scale

2015
Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.
    Archives of gynecology and obstetrics, 2015, Volume: 292, Issue:6

    Topics: Adenomyosis; Administration, Oral; Adult; Endometriosis; Female; Humans; Injections, Subcutaneous; Menorrhagia; Middle Aged; Nandrolone; Pelvic Pain; Premenopause; Prospective Studies; Treatment Outcome; Triptorelin Pamoate

2015
Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR.
    Fertility and sterility, 2015, Volume: 104, Issue:3

    Topics: Apoptosis; Autophagy; Cells, Cultured; Endometriosis; Enzyme Activation; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nandrolone; Ovarian Cysts; Phosphorylation; Progesterone; Proto-Oncogene Proteins c-akt; Signal Transduction; Stromal Cells; TOR Serine-Threonine Kinases

2015
Outcomes of treatment with cyclic administration of dienogest after ovarian endometriotic cystectomy.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2015, Volume: 31, Issue:8

    Topics: Adult; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Female; Humans; Laparoscopy; Nandrolone; Ovarian Cysts; Pelvic Pain; Retrospective Studies; Treatment Outcome; Young Adult

2015
Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest.
    Journal of endocrinological investigation, 2015, Volume: 38, Issue:11

    Topics: Adolescent; Adult; Endometriosis; Female; Follow-Up Studies; Hormone Antagonists; Humans; Nandrolone; Orgasm; Pelvic Pain; Quality of Life; Sexual Behavior; Treatment Outcome; Young Adult

2015
Use of dienogest over 53 weeks for the treatment of endometriosis.
    The journal of obstetrics and gynaecology research, 2015, Volume: 41, Issue:12

    Topics: Adult; CA-125 Antigen; Endometriosis; Estradiol; Female; Humans; Membrane Proteins; Middle Aged; Nandrolone

2015
Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study.
    Fertility and sterility, 2016, Volume: 105, Issue:3

    Topics: Adult; Cost-Benefit Analysis; Drug Costs; Drug Substitution; Endometriosis; Female; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Progestins; Quality of Life; Treatment Outcome

2016
Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:5

    Topics: Animals; Antineoplastic Agents, Hormonal; Disease Models, Animal; Endometrial Neoplasms; Female; Medroxyprogesterone Acetate; Mice; Nandrolone; Progestins; Treatment Outcome

2016
Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:8

    Topics: Adult; Disease-Free Survival; Endometriosis; Female; Follow-Up Studies; Hormone Antagonists; Humans; Japan; Laparoscopy; Nandrolone; Outcome Assessment, Health Care; Ovarian Diseases; Pain Measurement; Pelvic Pain; Recurrence; Retrospective Studies

2016
Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
    Journal of endocrinological investigation, 2016, Volume: 39, Issue:8

    Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Prognosis; Prospective Studies; Quality of Life; Sexual Behavior; Young Adult

2016
Primary umbilical endometriosis successfully treated with dienogest.
    Hormone molecular biology and clinical investigation, 2017, Feb-01, Volume: 29, Issue:2

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Umbilicus

2017
Impact of estrogen type on cardiovascular safety of combined oral contraceptives.
    Contraception, 2016, Volume: 94, Issue:4

    Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Nandrolone; Patient Reported Outcome Measures; Proportional Hazards Models; Prospective Studies; Surveys and Questionnaires; United States; Venous Thromboembolism; Young Adult

2016
Dienogest mediates midkine suppression in endometriosis.
    Human reproduction (Oxford, England), 2016, Volume: 31, Issue:9

    Topics: Adult; Ascitic Fluid; Cells, Cultured; Cytokines; Down-Regulation; Drug Discovery; Endometriosis; Endometrium; Female; Hormone Antagonists; Humans; Midkine; Nandrolone; Prospective Studies; Stromal Cells

2016
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2016, Volume: 76, Issue:4

    Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Microenvironment; Cytokines; Endometriosis; Endometrium; Estrogens; Female; Humans; Immunosuppression Therapy; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Stromal Cells; Tumor Necrosis Factor-alpha

2016
Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis.
    Archives of gynecology and obstetrics, 2016, Volume: 294, Issue:6

    Topics: Adult; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Nandrolone; Pelvic Pain; Recurrence

2016
Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis.
    European journal of obstetrics, gynecology, and reproductive biology, 2016, Volume: 207

    Topics: Adenomyosis; Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Apoptosis; Cell Proliferation; Combined Modality Therapy; Down-Regulation; Endometrium; Female; Humans; Immunohistochemistry; Middle Aged; Myometrium; Nandrolone; Nerve Fibers; Nerve Growth Factor; Neurogenesis; Progestins

2016
Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents.
    Journal of pediatric and adolescent gynecology, 2017, Volume: 30, Issue:5

    Topics: Absorptiometry, Photon; Adolescent; Bone Density; Child; Endometriosis; Europe; Female; Hormone Antagonists; Humans; Lumbar Vertebrae; Nandrolone; Pain Measurement; Pelvic Pain

2017
Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission.
    European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 211

    Topics: Adult; Constipation; Endometriosis; Female; Hormone Antagonists; Humans; Intestinal Diseases; Nandrolone; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Treatment Outcome

2017
Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density.
    European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 212

    Topics: Absorptiometry, Photon; Adult; Bone Density; Contraceptives, Oral; Endometriosis; Female; Femur Neck; Humans; Lumbar Vertebrae; Nandrolone; Prospective Studies; Secondary Prevention

2017
The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, Volume: 33, Issue:9

    Topics: Adult; Cytokines; Endometriosis; Endometrium; Female; Humans; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Stromal Cells; Tumor Necrosis Factor-alpha

2017
Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, Volume: 33, Issue:12

    Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Drug Evaluation, Preclinical; Endometriosis; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nandrolone; Rats, Wistar; Rosuvastatin Calcium

2017
Dienogest inhibits C-C motif chemokine ligand 20 expression in human endometriotic epithelial cells.
    European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 214

    Topics: Cell Line; Chemokine CCL20; Endometriosis; Epithelial Cells; Female; Humans; Interleukin-1beta; Mifepristone; Nandrolone; Receptors, Progesterone

2017
Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside.
    Expert opinion on drug metabolism & toxicology, 2017, Volume: 13, Issue:6

    Topics: Disease Progression; Drug Design; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone

2017
Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience.
    Archives of gynecology and obstetrics, 2017, Volume: 296, Issue:3

    Topics: Adolescent; Adult; Cohort Studies; Dyspareunia; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Treatment Outcome

2017
Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.
    European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 216

    Topics: Endometriosis; Female; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Ovarian Diseases; Pain; Peritoneal Diseases; Recurrence; Retrospective Studies; Secondary Prevention; Treatment Outcome

2017
Long-term use of dienogest in the treatment of painful symptoms in adenomyosis.
    The journal of obstetrics and gynaecology research, 2017, Volume: 43, Issue:9

    Topics: Adenomyosis; Adult; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone

2017
Environmental photochemistry of dienogest: phototransformation to estrogenic products and increased environmental persistence via reversible photohydration.
    Environmental science. Processes & impacts, 2017, Nov-15, Volume: 19, Issue:11

    Topics: Endocrine Disruptors; Estrogens; Kinetics; Models, Molecular; Models, Theoretical; Molecular Structure; Nandrolone; Photolysis; Ultraviolet Rays; Water Pollutants, Chemical

2017
Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma.
    Reproductive sciences (Thousand Oaks, Calif.), 2018, Volume: 25, Issue:3

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Pain Measurement; Recurrence; Retrospective Studies; Treatment Outcome; Ultrasonography; Young Adult

2018
Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, Volume: 33, Issue:sup1

    Topics: Adult; Endometriosis; Female; Fertilization in Vitro; Hormone Antagonists; Humans; Infertility, Female; Nandrolone; Ovarian Diseases; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Treatment Outcome

2017
Treatment of premenstrual mood changes in a patient with schizophrenia using dienogest: A case report.
    The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:4

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Premenstrual Syndrome; Schizophrenia

2018
Dienogest suppresses the activation of primordial follicles and preserves the primordial follicle stockpile for fertility in mice.
    Reproductive biomedicine online, 2018, Volume: 36, Issue:4

    Topics: Animals; Female; Fertility; Mice; Mice, Inbred ICR; Nandrolone; Ovarian Follicle; Ovary; Phosphorylation; Proto-Oncogene Proteins c-akt

2018
Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
    Reproductive biology and endocrinology : RB&E, 2018, Apr-03, Volume: 16, Issue:1

    Topics: Animals; Apoptosis; Atrophy; Cell Proliferation; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Endometrium; Female; Mice; Mice, Inbred C57BL; Nandrolone; Norpregnadienes; Progestins; Receptors, Progesterone; Recurrence

2018
Complete remission of cerebral endometriosis with dienogest: a case report.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:10

    Topics: Adult; Brain; Brain Diseases; Endometriosis; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Nandrolone; Treatment Outcome

2018
Symptom-alleviating effect and adverse effect of dienogest in Korean women with endometriosis.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:11

    Topics: Adult; Alopecia; Cross-Sectional Studies; Depression; Endometriosis; Female; Humans; Menstruation; Menstruation Disturbances; Middle Aged; Nandrolone; Pelvic Pain; Premenopause; Quality of Life; Recurrence; Republic of Korea; Surveys and Questionnaires; Time Factors; Weight Gain

2018
When Solving Dyspareunia Is Not Enough to Restore Sexual Function in Women With Deep Infiltrating Endometriosis Treated With Dienogest.
    Journal of sex & marital therapy, 2019, Volume: 45, Issue:1

    Topics: Adult; Brazil; Dyspareunia; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life; Sexual Dysfunction, Physiological; Treatment Outcome; Young Adult

2019
Long-term dienogest administration in patients with symptomatic adenomyosis.
    The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:8

    Topics: Adenomyosis; Adult; Female; Hormone Antagonists; Humans; Longitudinal Studies; Middle Aged; Nandrolone; Retrospective Studies

2018
Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data.
    Reproductive sciences (Thousand Oaks, Calif.), 2018, Volume: 25, Issue:10

    Topics: Adult; Amenorrhea; CA-125 Antigen; Endometriosis; Female; Hormone Antagonists; Humans; Multicenter Studies as Topic; Nandrolone; Pain; Pain Measurement; Recurrence; Retrospective Studies; Treatment Outcome

2018
Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
    The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:9

    Topics: Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Pain, Postoperative; Pelvic Pain; Young Adult

2018
Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries.
    The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:10

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Recurrence; Reoperation; Young Adult

2018
Combination of microwave endometrial ablation and postoperative dienogest administration is effective for treating symptomatic adenomyosis.
    The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:9

    Topics: Adenomyosis; Adult; Combined Modality Therapy; Dysmenorrhea; Endometrial Ablation Techniques; Female; Hormone Antagonists; Humans; Menorrhagia; Microwaves; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Retrospective Studies

2018
Comparison of dienogest and progesterone effects on uterine contractility in the extracorporeal perfusion model of swine uteri.
    Acta obstetricia et gynecologica Scandinavica, 2018, Volume: 97, Issue:11

    Topics: Animals; Area Under Curve; Extracorporeal Circulation; Female; Hormone Antagonists; Nandrolone; Progesterone; Progestins; Swine; Uterine Contraction

2018
Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice.
    Archives of gynecology and obstetrics, 2018, Volume: 298, Issue:4

    Topics: Adult; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Pelvic Pain; Retrospective Studies

2018
Effects of different progestins on prostaglandin biosynthesis in human endometrial explants.
    Contraception, 2019, Volume: 99, Issue:1

    Topics: Androstenes; Chlormadinone Acetate; Endometrium; Female; Humans; Nandrolone; Organ Culture Techniques; Progestins; Prostaglandins

2019
A case of unique endoscopic findings of intestinal endometriosis exposed to the mucosa: aggregation of papillary protruded bulges from the submucosal elevation of the rectum.
    Clinical journal of gastroenterology, 2019, Volume: 12, Issue:2

    Topics: Adult; Colonoscopy; Endometriosis; Female; Hormone Antagonists; Humans; Intestinal Mucosa; Nandrolone; Rectal Diseases

2019
Excerpts From the World Medical Literature.
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2018, Volume: 40, Issue:9

    Topics: Adenomyosis; Double-Blind Method; Female; Humans; Nandrolone; Pain

2018
Pain-related behavior and brain activation in cynomolgus macaques with naturally occurring endometriosis.
    Human reproduction (Oxford, England), 2019, 03-01, Volume: 34, Issue:3

    Topics: Acetaminophen; Analgesics; Animals; Behavior, Animal; Brain; Central Nervous System; Endometriosis; Female; Macaca fascicularis; Magnetic Resonance Imaging; Meloxicam; Morphine; Nandrolone; Pain

2019
Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
    European journal of obstetrics, gynecology, and reproductive biology, 2019, Volume: 236

    Topics: Adult; Contraceptives, Oral, Combined; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Nandrolone; Ovarian Diseases; Prospective Studies; Secondary Prevention; Young Adult

2019
Bioactive Rearrangement Products from Aqueous Photolysis of Pharmaceutical Steroids.
    Organic letters, 2019, 05-17, Volume: 21, Issue:10

    Topics: Molecular Structure; Nandrolone; Pharmaceutical Preparations; Photolysis; Steroids

2019
Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
    Maturitas, 2019, Volume: 123

    Topics: Androstenes; Animals; Breast Neoplasms; Cell Proliferation; Cyproterone Acetate; Dydrogesterone; Estradiol; Female; Heterografts; Humans; In Vitro Techniques; MCF-7 Cells; Megestrol; Membrane Proteins; Mice; Mice, Nude; Nandrolone; Norethindrone; Progesterone; Progestins; Prospective Studies; Receptors, Progesterone

2019
Umbilical endometriosis (Villar's nodule).
    American journal of obstetrics and gynecology, 2019, Volume: 221, Issue:6

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Umbilicus

2019
Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice.
    BMC women's health, 2019, 05-16, Volume: 19, Issue:1

    Topics: Adult; Asian People; Cohort Studies; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life; Severity of Illness Index; Treatment Outcome

2019
Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery?
    European journal of obstetrics, gynecology, and reproductive biology, 2019, Volume: 238

    Topics: Adult; Contraceptives, Oral, Hormonal; Endometriosis; Female; Humans; Nandrolone; Norethindrone; Ovarian Diseases; Retrospective Studies

2019
Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:1

    Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Endometriosis; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Pelvic Pain; Treatment Outcome; Young Adult

2020
Clinical aspects and management of inguinal endometriosis: A case series of 20 patients.
    The journal of obstetrics and gynaecology research, 2019, Volume: 45, Issue:10

    Topics: Adult; Endometriosis; Female; Gynecologic Surgical Procedures; Hormone Antagonists; Humans; Inguinal Canal; Magnetic Resonance Imaging; Middle Aged; Nandrolone; Recurrence; Retrospective Studies

2019
Severe hemoperitoneum due to endometriosis in a non-pregnant woman under dienogest therapy: a case report.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:3

    Topics: Adnexal Diseases; Adult; Endometriosis; Female; Hemoperitoneum; Hemostasis, Surgical; Hormone Antagonists; Humans; Laparoscopy; Ligaments; Nandrolone; Severity of Illness Index

2020
Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study.
    Journal of medical case reports, 2019, Oct-22, Volume: 13, Issue:1

    Topics: Adenocarcinoma, Clear Cell; Adult; Age Factors; Cell Transformation, Neoplastic; Contraceptives, Oral, Hormonal; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Ovarian Neoplasms; Parity; Retrospective Studies; Risk Factors

2019
Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:6

    Topics: Adenomyosis; Adult; Cohort Studies; Drug Administration Schedule; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Middle Aged; Nandrolone; Recurrence; Retrospective Studies; Treatment Outcome; Withholding Treatment

2020
Subtype I (intrinsic) adenomyosis is an independent risk factor for dienogest-related serious unpredictable bleeding in patients with symptomatic adenomyosis.
    Scientific reports, 2019, 11-27, Volume: 9, Issue:1

    Topics: Adenomyosis; Adult; Contraceptives, Oral, Hormonal; Female; Hemorrhage; Humans; Middle Aged; Nandrolone; Retrospective Studies; Risk Factors

2019
Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction.
    Molecular human reproduction, 2020, 01-01, Volume: 26, Issue:1

    Topics: Activating Transcription Factor 4; Adult; Apoptosis; Cell Movement; Cell Proliferation; Cysts; eIF-2 Kinase; Endometriosis; Endometrium; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endoribonucleases; Female; Gene Expression Regulation; Hormone Antagonists; Humans; MAP Kinase Kinase Kinase 5; MAP Kinase Signaling System; Nandrolone; Progesterone; Protein Serine-Threonine Kinases; RNA, Small Interfering; Stromal Cells; TNF Receptor-Associated Factor 2; Transcription Factor CHOP

2020
Efficacy of dienogest treatment of clinical symptoms of rectovaginal endometriosis.
    Ceska gynekologie, 2019,Summer, Volume: 84, Issue:5

    Topics: Cohort Studies; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Rectum; Treatment Outcome; Vagina

2019
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations.
    Nature communications, 2019, 12-19, Volume: 10, Issue:1

    Topics: Adenomyosis; Adult; Cell Proliferation; DNA Mutational Analysis; Endometriosis; Endometrium; Female; High-Throughput Nucleotide Sequencing; Humans; Hysterectomy; Middle Aged; Mutation; Myometrium; Nandrolone; Proto-Oncogene Proteins p21(ras); Receptors, Progesterone; Treatment Outcome; Young Adult

2019
Expression of Lewis (b) blood group antigen interferes with oral dienogest therapy among women with adenomyosis.
    Journal of reproductive immunology, 2020, Volume: 137

    Topics: Adenomyosis; Administration, Oral; Adult; Female; Hormone Antagonists; Humans; Lewis Blood Group Antigens; Nandrolone; Quality of Life; Retrospective Studies; Treatment Outcome

2020
Primary dysmenorrhea: new dose of an old medicine offers more options.
    Fertility and sterility, 2020, Volume: 113, Issue:1

    Topics: Double-Blind Method; Dysmenorrhea; Female; Humans; Medicine; Nandrolone

2020
Effect of Dienogest therapy on the size of the endometrioma.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:8

    Topics: Adult; Dysmenorrhea; Dyspareunia; Endometriosis; Endometrium; Female; Humans; Italy; Middle Aged; Nandrolone; Organ Size; Pelvic Pain; Peritoneal Diseases; Prospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult

2020
Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study.
    Advances in therapy, 2020, Volume: 37, Issue:5

    Topics: Adult; Endometriosis; Europe; Female; Germany; Hormone Antagonists; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Research Design; Women's Health

2020
Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas.
    Archives of gynecology and obstetrics, 2020, Volume: 302, Issue:4

    Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cystectomy; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Laparoscopy; Middle Aged; Nandrolone; Preoperative Period; Prospective Studies; Young Adult

2020
Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study.
    Acta obstetricia et gynecologica Scandinavica, 2021, Volume: 100, Issue:1

    Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Retrospective Studies; Risk Factors

2021
Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle.
    Reproductive biomedicine online, 2020, Volume: 41, Issue:5

    Topics: Adult; Birth Rate; Embryo Transfer; Endometriosis; Female; Fertilization in Vitro; Hormone Antagonists; Humans; Nandrolone; Oocyte Retrieval; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies

2020
New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone.
    Reproductive biology, 2021, Volume: 21, Issue:1

    Topics: Adult; Cohort Studies; Dydrogesterone; Endometriosis; Female; Humans; Nandrolone; Ovary; Pregnancy; Progestins; Prospective Studies

2021
Identification of biomarkers for drug-resistant endometriosis using clinical proteomics.
    Human cell, 2021, Volume: 34, Issue:2

    Topics: Antimicrobial Cationic Peptides; Blood Proteins; Carcinogenesis; Cell Line; Drug Resistance; Endometriosis; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Nandrolone; Proteomics

2021
The Long-Term Effect of Dienogest on Bone Mineral Density After Surgical Treatment of Endometrioma.
    Reproductive sciences (Thousand Oaks, Calif.), 2021, Volume: 28, Issue:5

    Topics: Adult; Bone Density; Endometriosis; Female; Humans; Nandrolone; Postoperative Complications; Retrospective Studies

2021
Evaluating the safety of dienogest in women with adenomyosis: A retrospective analysis.
    The journal of obstetrics and gynaecology research, 2021, Volume: 47, Issue:4

    Topics: Adenomyosis; Endometriosis; Female; Humans; Nandrolone; Retrospective Studies

2021
Dienogest reduces endometrioma volume and endometriosis-related pain symptoms.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2021, Volume: 41, Issue:8

    Topics: Adult; Contraceptives, Oral, Hormonal; Endometriosis; Endometrium; Female; Humans; Menstruation Disturbances; Nandrolone; Organ Size; Pain Measurement; Pelvic Pain; Prospective Studies; Treatment Outcome; Uterine Diseases

2021
Successful treatment of peritoneal inclusion cysts with dienogest: two case reports.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2022, Volume: 42, Issue:3

    Topics: Cysts; Endometriosis; Humans; Nandrolone; Peritoneal Diseases

2022
Cost-effectiveness Analysis of Dienogest Compared With Gonadotropin-Releasing Hormone Agonist After Conservative Surgery for Endometriosis in China.
    Clinical therapeutics, 2021, Volume: 43, Issue:8

    Topics: China; Cost-Benefit Analysis; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone

2021
Biotransformation of Current-Use Progestin Dienogest and Drospirenone in Laboratory-Scale Activated Sludge Systems Forms High-Yield Products with Altered Endocrine Activity.
    Environmental science & technology, 2021, 10-19, Volume: 55, Issue:20

    Topics: Androstenes; Biotransformation; Female; Humans; Laboratories; Nandrolone; Pregnancy; Progestins; Sewage

2021
Dienogest-induced major depressive disorder with suicidal ideation: A case report.
    Medicine, 2021, Oct-08, Volume: 100, Issue:40

    Topics: Adult; Depressive Disorder, Major; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Suicidal Ideation

2021
A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022, Volume: 38, Issue:2

    Topics: Adenomyosis; Cohort Studies; Dysmenorrhea; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Nandrolone

2022
Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN.
    Reproductive sciences (Thousand Oaks, Calif.), 2022, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Amenorrhea; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life

2022
A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022, Volume: 38, Issue:5

    Topics: Adult; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life; Treatment Outcome

2022
Autoimmune progesterone dermatitis treated with dienogest: A case report.
    The Journal of dermatology, 2022, Volume: 49, Issue:10

    Topics: Autoimmune Diseases; Dermatitis; Humans; Nandrolone; Progesterone

2022
Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.
    Journal of Korean medical science, 2022, 07-04, Volume: 37, Issue:26

    Topics: Contraception; Contraceptives, Oral; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Retrospective Studies; Secondary Prevention

2022
Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022, Volume: 38, Issue:8

    Topics: Adenomyosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Retrospective Studies; Treatment Outcome

2022
Cost-effectiveness Analysis of Dienogest Compared with Combined Oral Contraceptives after Surgery for Endometriosis.
    Journal of minimally invasive gynecology, 2023, Volume: 30, Issue:4

    Topics: Contraceptives, Oral, Combined; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Endometriosis; Female; Humans; Nandrolone; Quality-Adjusted Life Years

2023
Is dienogest a convenient treatment option for cesarean scar endometriosis or should it be treated surgically?
    European journal of obstetrics, gynecology, and reproductive biology, 2023, Volume: 282

    Topics: Adult; Cicatrix; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Treatment Outcome

2023
Quality of life and clinical factors in women with endometriosis, the role of dienogest vs EE/dienogest over time: a single-center study.
    Archives of gynecology and obstetrics, 2023, Volume: 307, Issue:5

    Topics: Dysmenorrhea; Endometriosis; Female; Humans; Nandrolone; Quality of Life; Treatment Outcome

2023
Genome-Wide Gene Expression Profiling Reveals the Direct Effect of Dienogest on Ovarian Endometriotic Stromal Cells.
    Reproductive sciences (Thousand Oaks, Calif.), 2023, Volume: 30, Issue:8

    Topics: Endometriosis; Female; Gene Expression Profiling; Humans; Nandrolone; Progestins; Stromal Cells

2023
Dienogest Use for Recurrent Pyosalpinx as a Long-Term Complication of Cloacal Exstrophy: A Case Report.
    Journal of pediatric and adolescent gynecology, 2023, Volume: 36, Issue:3

    Topics: Abdominal Pain; Adolescent; Adult; Bladder Exstrophy; Female; Humans; Nandrolone; Salpingitis; Urogenital Abnormalities; Young Adult

2023
Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery.
    BMC women's health, 2023, 02-24, Volume: 23, Issue:1

    Topics: Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Nandrolone

2023
Endometriosis features and dienogest tolerability in women with depression: a case-control study.
    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2023, Volume: 28, Issue:3

    Topics: Case-Control Studies; Depression; Dysmenorrhea; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain

2023
Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study.
    Archives of gynecology and obstetrics, 2023, Volume: 308, Issue:4

    Topics: Dysmenorrhea; Dysuria; Endometriosis; Estradiol; Estrogens; Female; Humans; Nandrolone; Retrospective Studies

2023